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ABSTRACT
Chronic low-grade inflammation and exposure to stress are key contributing factors in the
etiology and progression of many neuropsychiatric disorders. Dietary emulsifiers are commonly
added to processed foods and are classified by the Food and Drug Administration (FDA) as
generally recognized as safe (GRAS). Recently, however, it has been revealed that these
additives at translationally relevant doses can cause low-grade inflammation, gut dysbiosis, and
may even increase baseline anxiety-like behavior. The latter finding suggests that dietary
emulsifiers impact brain areas that modulate stress responses. We used RNA-Seq to examine
whether chronic consumption of either polysorbate 80 (P80) or carboxymethylcellulose (CMC)
is associated with changes in gene expression in the amygdala and PVN and used Ingenuity
Pathway Analysis to identify enriched molecular pathways that may underlie an anxiety-like
phenotype. Emulsifier consumption resulted in alterations in gene expression of various
immediate early, stress-related, and immune-related genes in brain regions that are known to be
important in the generation of behavioral and neuroendocrine responses to stress-provoking
stimuli. We also hypothesized that emulsifier-treated mice exhibit sensitized behavioral,
hormonal, and neuronal activity responses to stress. To test this hypothesis, C57Bl6/J mice were
subjected to acute defeat conditions after 12 weeks of emulsifier or water consumption. When
subjected to social defeat, emulsifier-treated mice showed increases in social avoidance and
circulating corticosterone as well as alterations in neuronal activity as measured by c-Fos
immunofluorescence. Subsequently, given the observed increased expression of PTGS2 (COX2) in the amygdala, we tested the hypothesis that increased inflammation through the COX
pathway is a mechanism driving emulsifier-induced increases is stress sensitivity. Groups were
as described above, but mice were also divided into aspirin (25mg/kg/day) and placebo

intervention groups. We found that aspirin, a COX pathway inhibitor, appears to block the
increase in social avoidance observed in emulsifier-treated mice. These data demonstrate that
ingestion of dietary emulsifiers at concentrations analogous to those ingested by humans
increases sensitivity to social stress in mice. Further, it appears that the COX pathway may be a
prime mechanistic candidate by which emulsifier-induced increases in sensitivity to social stress
occurs.
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1.1

1

INTRODUCTION

Overview
Various studies provide evidence that immunological stress, often in the form of lowgrade inflammation, may be a mechanism underlying mood disorders. Chronic physical
stressors like inflammation and chronic psychological stressors such as social stress can
disrupt the hypothalamic-pituitary-adrenal (HPA) axis, which is the main modulator of the
body’s neuroendocrine response to stress [1-6]. It has been proposed that a chronic
inflammatory state ultimately leads to a hyperactive HPA-axis, resulting in increased longterm release of glucocorticoids, which could then result in anxiety- and depression-like
phenotypes [7-9]. Further, chronic psychological stress can amplify the HPA response to an
immune challenge and, reciprocally, inflammatory stress can amplify the HPA response to a
psychological stressor, suggesting that there could be feedback or feedforward loops that
change HPA axis responsivity [10, 11]. The immune system interacts with stress-regulatory
brain areas to affect the brain and behavior by altering neurochemical signaling,
neuroplasticity, and neuroendocrine processes [3, 12]. Reciprocally, stress exposure can
activate inflammatory immune responses [13].
A potential environmental source of immunological activation or stress for
humans is chronic consumption of a pro-inflammatory diet. Certain dietary components, such
as trans fatty acids and saturated fatty acids, have been shown to stimulate chronic, low-grade
inflammation and thereby could increase susceptibility to developing a neuropsychiatric
disorder [6, 14-16]. Food additives, such as emulsifiers that are used as food stabilizers, are
commonly added to processed foods. These additives are generally viewed as innocuous and
are classified by the Food and Drug Administration (FDA) as “generally recognized as safe”
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(GRAS). Recently, however, it has been revealed that these additives at translationally
relevant doses can cause systemic inflammation [17, 18]. It has also been suggested that mice
consuming emulsifiers may display an anxiety-like behavioral phenotype [18]. It is not
known, however, whether emulsifier-treated animals exhibit normal behavioral and
neuroimmune responses to stress. Arguably, the most common stressor experienced by most
animals is social stress. Social stress is of particular interest because it is a salient, naturally
occurring stressor experienced by all social animals, including rodents and humans [19].
Social stress in humans has been shown to contribute to the etiology and progression of
mood and anxiety disorders, and, similarly, non-human animals that experience social stress
exhibit anxiety- and depression-like phenotypes [20-24]. Altogether, it is conceivable that a
chronic, low-grade inflammatory state induced by emulsifier consumption may increase
physiological and behavioral responses to social stress. Thus, the purpose of this project is
to test whether dietary emulsifiers increase sensitivity to social stress and, if so, whether
they do so, at least in part, by stimulating a pro-inflammatory state.
1.2

Emulsifiers
Dietary emulsifiers are the most common food additive found in processed
foods[25]. In fact, processed foods and beverages usually contain one or more emulsifiers
that are used to stabilize mixtures, extend shelf life, and to enhance texture, uniformity, and
volume [26]. Although these additives are recognized as safe for consumption by the FDA, it
has been recently reported that these additives at translationally relevant doses can cause
systemic inflammation and gut dysbiosis [14, 17, 18]. Specifically, the consumption of
emulsifiers reduces microbial diversity and increases inflammation-promoting
proteobacteria. Further, emulsifiers may disrupt the protective mucosal barrier in the gut,
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allowing bacteria to translocate to the intestine's epithelial lining and resulting in an innate
immune response and a pro-inflammatory cascade [17, 27]. Animals fed emulsifiers may be
more susceptible to inflammation-driven disorders such as colitis, metabolic disorders, and
colorectal cancer [17, 28]. Further, these phenotypes are transferrable via microbiota
transplant from emulsifier-treated animals, suggesting that microbiota composition is a
mechanism by which these disordered phenotypes arise [17, 28]. Emerging data indicate that
emulsifier-treated animals may also display a baseline anxiety-like behavioral phenotype
[18], suggesting that emulsifier-induced inflammation may also impact the brain. The
mechanism whereby emulsifiers might contribute to the development of an anxiety-like
behavioral phenotype, however, has yet to be determined.
It is possible that altered gene expression in areas of the brain that play a major
role in modulating anxiety and stress responding, such as the amygdala and paraventricular
nucleus of the hypothalamus (PVN), may be contributing to the anxiety-like behavioral
phenotype following ingestion of emulsifiers. It is also possible that emulsifiers alter
immune-related gene expression in the brain and that this contributes to an altered behavioral
and neuroendocrine stress response, as many studies have demonstrated that alterations in
neuro-immune signaling pathways can affect stress responding[29, 30]. Thus, the purpose of
Aim 1 was to test whether the consumption of emulsifiers, at doses that are used by the
food industry, is sufficient to alter gene expression in the brain. Such a result would
suggest that dietary emulsifiers have a much more profound impact on the brain than has
been previously known. The discovery of what gene pathways are impacted by emulsifiers
could also give us an idea of potential mechanisms whereby these compounds might alter
responses to stress.
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Social Defeat Stress
Social stress is a commonly encountered stressor for most animals and is a major
contributing factor in the etiology of a variety of stress-related diseases in humans [19]. The
most common form of social stress experienced by animals is social defeat stress. Social
defeat models, wherein an animal loses, or is defeated, in a confrontation with a conspecific,
are widely used and are thought to have strong ethological and face validity [31-33]. Social
defeat stress reliably induces anxiety- and depression-like phenotypes and is a naturally
occurring stressor present in the environment of social animals [19, 32]. Humans and many
other animals show increased social avoidance after social defeat [22, 31, 33, 34], and social
avoidance is a prominent symptom of a variety of neuropsychiatric disorders including mood
and anxiety disorders, post-traumatic stress disorder, and schizophrenia [21, 35, 36]. For
these reasons, social defeat is often used in studies that investigate the relationship between
stress and neuropsychiatric disease.
In the context of studying how social stress may interact with inflammation to
produce or exacerbate neuropsychiatric disorders, it has recently been demonstrated that
social defeat-induced anxiety in mice is correlated with various peripheral pro-inflammatory
cytokines [37]. Thus, the use of social defeat as a stressor to test stress sensitivity in
emulsifier-treated animals is ideal because emulsifiers stimulate peripheral inflammation,
which we predict will make them more susceptible to social stress. Thus, the purpose of
Aim 2 is to test whether emulsifier consumption increases sensitivity to social stress.

1.4

Inflammation, Social Stress, and Neuropsychiatric Disorders
Inflammation is an immune response mediated by immune cells and various
molecular signals, such as cytokines and prostaglandins, working in concert to eliminate
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pathogens, irritants, and unhealthy or damaged cells. Acute inflammation lasts hours to days
and ceases immediately after the removal of the immune threat. In conditions where the
threat is sustained or becomes dysregulated and anti-inflammatory molecular mediators are
unable to inhibit the pro-inflammatory immune reaction, a chronic inflammatory state may
result [38]. This chronic activation can result in increased tissue damage and can increase
susceptibility to neuropsychiatric disease by disrupting neuroendocrine homeostasis [14, 39].
Elevated pro-inflammatory markers such as c-reactive protein (CRP), interleukin6 (IL-6), interleukin-17 (IL-17), tumor necrosis factor alpha (TNFa), and interleukin 1
receptor antagonist (Il-1Ra) are associated with neuropsychiatric disorders including anxiety,
depression, post-traumatic stress disorder (PTSD), and schizophrenia [6, 40-42]. Further,
various autoimmune disorders including rheumatoid arthritis, diabetes, hepatitis, sepsis,
Crohn’s disease, and psoriasis are associated with a greater risk of developing a mood
disorder [43-45]. Studies in both humans and mice that have experimentally induced a
proinflammatory state through endotoxin exposure or exogenous administration of cytokines
support the hypothesis that inflammation is a driving factor in the development of mood
disorder, as subjects in these studies demonstrated various neuropsychiatric symptoms such
as anhedonia, social avoidance, anxiety, and cognitive impairment [46-48]. Collectively,
these findings demonstrate a positive association between inflammatory mechanisms and
neuropsychiatric symptoms.
Stressors, particularly social stressors, can increase inflammatory activity in a
manner that may promote neuropathology as discussed earlier. Furthermore, the relationship
between social stress and inflammation appears to be bidirectional, as inflammation can
increase neural and behavioral sensitivity to social stress and vice versa [49]. Under acute
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conditions this bidirectional relationship is highly adaptive, in that stress-induced immune
activation prepares the body for potential physical harm from an environmental threat and
reciprocally, immune-induced sensitization of the stress response increases vigilance when
the body is vulnerable [50, 51]. Under chronic conditions, however, social stress and
inflammation can result in an anxiety and depression-like phenotype. Social stressors may
interact with pro-inflammatory conditions to produce or exacerbate neuropsychiatric
disorders, as both dietary inflammation and social stress are major predisposing risk factors
in the development of stress-related disease in humans [14, 23, 24, 52]. Further investigation
of inflammatory mechanisms that underlie increased susceptibility to stress-related pathology
are essential to inform novel, improved therapeutic strategies to treat these disorders.
1.4.1

Prostaglandins

Peripheral inflammation from the gut can signal to the central nervous system (CNS)
by multiple routes such as systemic circulation of cytokines which can disrupt the blood
brain barrier, migration of gut-derived immune cells that translocate to the CNS, and afferent
vagus nerve fibers [53-56]. In response to afferent inflammatory signals, a
neuroinflammatory response is mounted in the CNS that consists of the release of
inflammatory cytokines. A primary mediator of this cytokine cascade are prostaglandins,
which are synthesized by cyclooxygenase (COX) enzymes in endothelial and perivascular
cells as well as by microglia, the brain’s resident immune cells [57-59]. Under inflammatory
conditions, prostaglandins regulate HPA activity [60, 61]. Reciprocally, chronic activation of
the HPA-axis through repeated restraint stress elevates constitutive COX1 and inducible
COX2 cyclooxygenase in the PFC, hippocampus and hypothalamus [62]. Interestingly, basal
expression of COX2 is restricted to areas of the brain that regulate stress responding, which

CONSUMPTION OF DIETARY EMULSIFIERS

7

includes the basolateral amygdala where it is upregulated after stress exposure [63-65]. Other
studies show that increased COX2 expression in the brain promotes susceptibility to chronic
mild unpredictable stress in rats, and COX2 inhibition decreases anxiety-like behavior in
mice and decreases glutamatergic activity in the amygdala [66, 67]. Further, pharmacological
inhibition of the COX pathway has shown promise in clinical trials investigating its
therapeutic potential to reduce symptoms of major depression [68, 69]. Taken together, the
COX molecular pathway may be a prime mechanistic candidate driving emulsifier-induced
increases in sensitivity to stress and a promising alternative or adjunctive treatment for stressrelated neuropsychiatric disorders. Thus, the purpose of AIM 3 is to test the hypothesis
that inflammation, specifically through the COX pathway, is a mechanism driving
emulsifier-induced stress sensitivity.
1.5 Specific Aims Overview
1.5.1 Aim 1: Does consumption of dietary emulsifiers alter gene expression in
brain regions that modulate the stress response?
Emulsifier-treated animals show increased peripheral inflammation and perhaps
baseline anxiety-like behavior [18]. It is not yet known if emulsifiers induce inflammation
centrally. It is possible that emulsifiers induce immune-related gene expression in the brain
and that this contributes to altered stress behavior, as many studies have demonstrated that
alterations in neuro-immune signaling pathways can affect stress responding[29, 30]. Altered
gene expression in areas of the brain, such as the amygdala and PVN, that modulate
behavioral and physiological responses to stress could be responsible for the anxiety-like
behavioral phenotype. Further, identifying immune and stress-related genes may elucidate
candidate mechanisms by which emulsifier consumption might alter stress-related behavior.
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The purpose of this aim was to determine whether a supposedly innocuous dietary
manipulation, namely the addition of low concentrations of emulsifiers, could elicit changes
in gene expression in the brain. This is examined in two brain areas, the amygdala and the
PVN, that are known to be critical for regulating behavioral and neuroendocrine responses to
stress and known to be dysregulated in stress-induced neuropsychiatric disorders [32]. Using
RNA-Seq, differential gene expression within the amygdala and PVN is compared between
animals that consume emulsifiers in their drinking water versus controls drinking plain water.
1.5.2 Aim 2: Does emulsifier consumption increase susceptibility to social stress?
Initial data suggest that emulsifier-treated animals may display a baseline anxiety-like
behavioral phenotype on a subset of behavioral tests thought to be reflective of anxiety-like
responses [18]. It is not yet known whether animals that consume emulsifiers also show an
enhanced stress response when subjected to stress. We hypothesize that emulsifier-treated
animals show increased sensitivity to social stress. Experiment 2a will test whether
emulsifier consumption increases social avoidance in response to social defeat, which is a
highly salient social stressor. Experiment 2b will test whether emulsifier consumption
increases serum corticosterone following social defeat. Experiment 2c will examine c-Fos
protein expression, a marker of neuronal activity, in brain regions that are critical for
behavioral and hormonal responses to stress to determine whether emulsifiers increase
activation of stress-related brain regions following exposure to social defeat stress.
1.5.3 Aim 3: Does an anti-inflammatory intervention, specifically Cox pathway
inhibition, ameliorate emulsifier-induced increases in vulnerability to social stress?
Increased COX2 expression in the brain enhances susceptibility to chronic mild
unpredictable stress in rats, and Cox pathway inhibition decreases anxiety-like behavior in

CONSUMPTION OF DIETARY EMULSIFIERS

9

mice [66, 67]. Thus, the Cox pathway may be a prime mechanistic candidate driving
emulsifier-induced stress sensitivity. We hypothesize that aspirin, a Cox pathway
inhibitor, can ameliorate the increased vulnerability to social stress induced by
emulsifiers. Experiment 3a will test whether treatment with low-dose aspirin (25mg/kg/day)
decreases social avoidance in emulsifier-treated animals. Experiment 3b will test whether
treatment with low-dose aspirin decreases the corticosterone response to a social stressor.
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DIETARY EMULSIFIER CONSUMPTION ALTERS GENE EXPRESSION IN THE
AMYGDALA AND PARAVENTRICULAR NUCLEUS OF THE HYPOTHALAMUS
IN MICE

2.1

Introduction
Chronic low-grade inflammation has recently been identified as a key contributing factor

in the etiology and progression of neuropsychiatric disorders [1, 2]. The immune system interacts
with stress regulatory brain areas to affect brain and behavior by altering neurochemical
signaling, neuroplasticity, and neuroendocrine processes [3, 4]. One common source of lowgrade inflammation originates from the gastrointestinal tract when the host/microbiota
interaction is altered through agents such as dietary factors. Indeed, select dietary components
can lead to chronic, low-grade inflammation and may thereby increase susceptibility to
developing a neuropsychiatric disorder [2, 5]. Food and drink additives, such as emulsifiers, are
commonly added to processed foods and many beverages to improve texture, consistency, and to
extend shelf-life. Although these additives are generally viewed as innocuous and are classified
by the Food and Drug Administration as Generally Recognized As Safe, it has been recently
reported that these additives at translationally relevant doses can cause systemic inflammation
[5-7]. Specifically, consumption of emulsifiers, such as carboxymethylcellulose (CMC) and
polysorbate-80 (P80), appear to reduce microbial diversity and to increase inflammationpromoting proteobacteria. CMC and P80 appear to act through different mechanisms on the
intestinal microbiota in a way that promotes chronic intestinal inflammation that manifests as
colitis in genetically susceptible mice and metabolic deregulations in mice that are not
genetically susceptible [6, 8]. Importantly, these phenotypes are abolished in germ-free mice and
are transferrable via microbiota transplant from emulsifier-treated mice to germ-free mice,
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suggesting that the intestinal microbiota is both required and sufficient to drive emulsifierinduced detrimental effects [6, 8]. Interestingly, previous data suggest that emulsifier-treated
animals may also display an anxiety-like behavioral phenotype [7], suggesting that emulsifierinduced shifts in the microbiome may also impact the brain. The mechanism whereby emulsifiers
contribute to the development of an anxiety-like behavioral phenotype, however, has yet to be
determined.
Stress-related disorders are often characterized by dysregulation of the hypothalamicpituitary-adrenocortical (HPA) axis [9], the neuroendocrine cascade that is a key modulator of
the body’s response to stress[9]. Furthermore, the HPA axis has a bi-directional relationship with
the innate immune system as well as with the gut microbiota[10, 11]. Sustained activation of the
HPA axis can affect gut microbial composition and gastrointestinal permeability[12].
Conversely, antibiotic-induced gut dysbiosis can sensitize the HPA axis, resulting in excessive
stress hormone release after acute stress exposure[13]. It is possible that altered gene expression
in areas of the brain that play a major role in modulating anxiety and stress responding, such as
the amygdala and paraventricular nucleus of the hypothalamus (PVN), may be responsible for
the anxiety-like behavioral phenotype following ingestion of emulsifiers. It is also possible that
emulsifiers induce inflammation in the brain and that this contributes to an altered behavioral and
neuroendocrine stress response, as many studies have demonstrated that alterations in neuroimmune signaling pathways can affect stress responding[14, 15]. Hence, the purpose of this
present study was to test whether consumption of emulsifiers at doses used by the food industry
are sufficient to alter gene expression in the brain in a way that might illuminate how these
compounds alter stress responding and anxiety-like states. Using RNA-sequencing, we
investigated whether emulsifier consumption alters gene expression in two critical stress-
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modulatory brain regions, the amygdala and PVN. We hypothesized that ingestion of emulsifiers
alters immune and stress-related gene expression in both the amygdala and PVN. Overall, we
present a comprehensive genome-wide analysis of differentially expressed genes after emulsifier
consumption in two brain regions that modulate the stress response.
2.2
2.2.1

Results
Verification of emulsifier-induced metabolic syndrome and low-grade inflammation
To verify that the animals used in the RNA-Seq and qRT-PCR validation experiment

display the previously described low-grade inflammation and altered metabolic phenotype, the
body weight of each subject was measured throughout the duration of the study and organs were
weighed at the time of sacrifice. Animals that consumed emulsifiers showed a significant
increase in weight over time (Figure 2.1.a; p=.0279) and increased adiposity, measured by fat
pad weight (Figure 2.1.b; CMC vs Water, p=.0002 and P80 vs Water, p=<.0001). Mice that
consumed emulsifiers also had significantly shorter colons (Figure 2.1.c; CMC vs Water,
p=<.0001 and P80 vs Water, p=.008) and increased spleen weight (Figure 2.1.d; CMC vs Water,
p=<.0001 and P80 vs Water, p=.0015), a phenotype that results from low-grade inflammation.
Altogether, these data verify that the animals used in the RNA-Seq and qRT-PCR validation
study display a phenotype consistent with metabolic syndrome and low-grade inflammation.
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Figure 2.1 Emulsifier consumption results in metabolic syndrome and low-grade
inflammation
Note. (a) Relative body weight over time. Body weight is expressed as a percentage compared to the
initial body weight (Day 0) defined as 100%. Ingestion of emulsifiers significantly increased fat-pad mass
(b), decreased colon length (c), and increased spleen weight (d) compared to controls. Significance was
determined using a repeated measure one-way ANOVA with a Geisser-Greenhouse correction (#p < 0.05)
or unpaired t-tests (*p < 0.05). N=5 in each group.

2.2.2

Consumption of dietary emulsifiers alter hypothalamic and amygdala gene expression
To identify potential mechanisms by which emulsifier exposure could alter anxiety-like

behavior, we applied an unbiased approach and performed total mRNA sequencing of the
amygdala and PVN regions, known to play a central role in stress-responding and anxiety-like
behaviors. Importantly, we observed that emulsifier consumption is associated with the
modulation of gene expression in the amygdala and the PVN. Volcano plots and Venn diagrams
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were generated to broadly show the number of genes that were changed in the amygdala and
PVN after each emulsifier treatment compared to water-only controls. Figure 2.2 demonstrates
that a relatively low number of genes were found to be significantly differentially expressed
(padj < .05, Log2 FC > 1 and <-1) in the amygdala (Figures 2.2.a and 2.2.b) and PVN (Figures
2.2.c and 2.2.c). Only genes that fit differential expressed gene (DEG) criteria were used for
subsequent analyses (Figures 3-5 and Tables 1-3). As presented in Figure 2.3, the number of
shared and different DEGs between emulsifier conditions in each brain region is relatively low
compared to the total number of variables studied (18,778). In total, 243 genes were
differentially expressed in the amygdala and PVN of emulsifier-treated animals compared to
control animals. Counts include 56 unique DEGs in the amygdala after CMC treatment and 59
with P80 treatment. In addition, 52 unique DEGs were counted in the PVN after CMC treatment
and 76 with P80 treatment. 9 DEGs were shared between CMC- and P80-treated mice in the
amygdala and 9 DEGs were shared between CMC- and P80-treated mice in the PVN.
Importantly, of the differentially expressed genes shared in common between CMC and P80,
several were immediate early genes (IEGs), which are widely used as a molecular marker of
neuronal activity. Emulsifier treatment increased expression of IEGs such as NR4A3, EGR2,
FOSB, and FOSL2 in the amygdala and PVN, suggesting that both CMC and P80 may increase
neuronal activity in these brain regions. A hierarchical heat map (Figure 2.4), grouping genes
with similar transcriptional profiles into clusters, was included to show the direction of
differential expression of each DEG and global DEG patterns occurring within (comparing
individuals within each group) and between (water versus emulsifier) conditions.
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Figure 2.2 Dietary emulsifier consumption alters gene expression in the amygdala and
paraventricular nuclei of the hypothalamus
Note. Wild-type (WT) mice were exposed to plain drinking water or water containing CMC or P80
(1.0%) for 12 weeks and brain tissue was harvested. The extent of tissue punch in the amygdala (a) and
PVN (b). Sections adapted from Paxinos, George, and Franklin 2001.Total RNAs were extracted,
mRNAs purified, and subjected to library preparation and sequencing. Genes were filtered to keep only
genes expressed in at least one condition (average FPKM (Fragments Per Kilobase Million) > 1 in at least
one group) and were visualized on volcano plots. (c) Water-treated versus CMC-treated, amygdala. (d)
Water-treated versus P80-treated, amygdala. (e) Water-treated versus CMC-treated, paraventricular
nucleus. (f) Water-treated versus P80-treated, paraventricular nucleus. For each gene, the difference in
abundance between the two groups is indicated in log2 fold change on the x-axis (with positive values
corresponding to an increase in the emulsifier-treated group compared with the water-treated group, and
negative values corresponding to a decrease in the emulsifier-treated group compared with the watertreated group). Log2 fold values that exceeded 10 or -10 are recorded as 10 or -10. Significance between
the two groups is indicated by −log10 p-value on the y-axis. Red dots correspond to genes with adj.
p<0.05 between emulsifier-treated and water-treated groups. Orange dots correspond to genes with at
least a one-fold decreased or increased expression in the emulsifier-treated group compared with the
water-treated group. Green dots represent differentially expressed genes (adj. p<0.05, log2 FC >1 and <1) between control and emulsifier groups. Only genes in green were used for subsequent analysis.
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Figure 2.4 Heat maps show z-score normalized relative expression of differentially
expressed genes that met criteria maps show z-score normalized relative expression of
differentially expressed genes that met criteria
Note. Heatmaps show z-score normalized relative expression of differentially expressed genes that met
criteria (FC >1, adj.p-value <0.05). Hierarchical clustering based on Euclidian distance of 56
differentially expressed genes in the amygdala after CMC treatment and 59 with P80 treatment. 52
differentially expressed genes in the PVN after CMC treatment and 76 with P80 treatment are listed.
Genes are indicated in rows and animals are in columns. Blue indicates downregulation and red
upregulation of the differentially expressed genes. Heatmaps were generated using the gplots and
RColorBrewer libraries in R
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Gene Ontology
To explore the potential biological meaning of the identified differentially expressed

genes, we next used EnrichR to perform gene ontology to identify biological processes or
molecular functions (Table 2.1 and Table 2.2) involved[16-18]. Analysis of gene ontology
yielded statistically significant (p-value < .05) enriched terms. An important stress and immune
function term, “glucocorticoid receptor binding” was enriched in both CMC and P80 conditions,
which may suggest possible HPA-axis dysfunction under both emulsifier conditions. DEGs
known to code for protein that regulate glucocorticoid receptor (GR) binding include Nuclear
Receptor Subfamily 4 Group A Member 3 (NR4A3, ^), Nuclear Receptor Subfamily 4 Group A
Member 2 (NR4A2, ^), and Serum- and Glucocorticoid-inducible Kinase 1 (SGK1, ^).
Specifically, NR4A3 and NR4A2 transcription factors inhibit GR-dependent repression of the
POMC gene, a gene that encodes the precursor protein needed to synthesize ACTH. Further,
both NR4A3 and NR4A2 have been shown to regulate HPA-axis neuroendocrine activity within
the PVN, pituitary, and adrenals[19]. SGK1 potentiates and prolongs GR activation following
cortisol stimulation by increasing GR phosphorylation and nuclear translocation [20]. SGK1 is
both a downstream target of GR signaling and also affects GR activation by positively regulating
the long-lasting effects of glucocorticoids[21]. The increase in differential expression of the
above-mentioned genes in our dataset may suggest alterations in HPA-axis activity in animals
that consume emulsifiers. Interestingly, several metabolism-related pathways were also enriched
in the PVN as a result of emulsifier consumption. For example, for the CMC-induced
deregulated DEGs, these pathways included “regulation of triglyceride metabolic process,”
“regulation of lipoprotein lipase activity,” “regulation of lipid biosynthetic process,”
“acylglycerol homeostasis,” and “triglyceride homeostasis,” whereas the P80-induced
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deregulated DEGs included metabolic-related terms such as “insulin-like growth factor” I and II
binding. These data suggest possible neural mechanisms that may contribute to the
dysfunctional metabolic phenotype previously described in emulsifier-treated mice[6].
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Table 2.1 Gene Ontology of differentially expressed genes in the amygdala of emulsifier treated mice
Gene Ontology Functional Enrichment Analysis
Amygdala- CMC vs Water
GO ID
Biological Process Description
GO:0031643
positive regulation of myelination
GO:0045444
fat cell differentiation
GO:0031646
positive regulation of nervous system process
GO:0031641
regulation of myelination
GO:0099643
signal release from synapse
GO:0007269
neurotransmitter secretion
GO:0031620
regulation of fever generation
GO:0031394
positive regulation of prostaglandin biosynthetic
GO:1903208
negative regulation of hydrogen peroxide-induced
process
GO:2000253
positive regulation of feeding behavior
neuron
death
GO ID
Molecular
Function Description
GO:0035259
glucocorticoid receptor binding
GO:0001228
DNA-binding transcription activator activity, RNA
GO:1990837
sequence-specific double-stranded DNA binding
polymerase
II-specific
GO:0016907
G protein-coupled
acetylcholine receptor activity
GO:0099528
G protein-coupled neurotransmitter receptor activity
GO:2001069
glycogen binding
GO:0017017
MAP kinase tyrosine/serine/threonine phosphatase
GO:0008330
protein tyrosine/threonine phosphatase activity
activity
GO:0035497
cAMP response element binding
GO:0061665
SUMO ligase activity
Amygdala- P80 vs Water
GO ID
Biological Process Description
GO:0048539
bone marrow development
GO:0086018
SA node cell to atrial cardiac muscle cell signaling
GO:0014037
Schwann cell differentiation
GO:0044843
cell cycle G1/S phase transition
GO:0060441
epithelial tube branching involved in lung
morphogenesis

p-value
4.02E-04
5.46E-04
1.10E-03
2.31E-03
6.24E-03
6.52E-03
1.37E-02
1.37E-02
1.37E-02
1.37E-02
p-value
2.64E-04
2.19E-03
1.31E-02
1.91E-02
1.91E-02
2.18E-02
2.72E-02
2.72E-02
2.72E-02
2.72E-02

DEGs
RNF10;EGR2
NR4A2;EGR2;NR4A3
RNF10;EGR2
RNF10;EGR2
PCLO;HRH3
PCLO;HRH3
PTGS2
PTGS2
NR4A3
NR4A3
DEGs
NR4A2;NR4A3
NR4A2;EGR2;NR4A3;EGR4;FOSL2
NR4A2;RNF10;EGR2;EGR4;FOSB;JUNB
HRH3
HRH3
PPP1R3G
DUSP5
DUSP5
NR4A3
EGR2

p-value
1.49E-02
1.49E-02
1.49E-02
1.54E-02
1.79E-02

DEGs
LRRC17
SCN3B
EGR2
CDKN1A;GSPT1
NKX2-1
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GO:0032020
ISG15-protein conjugation
1.79E-02
ISG15
GO:0060373
regulation of ventricular cardiac muscle cell membrane
1.79E-02
SCN3B
GO:0044058
regulation of digestive system process
1.79E-02
SGK1
depolarization
GO:0060371
regulation of atrial cardiac muscle cell membrane
2.08E-02
SCN3B
GO:0086015
SA node cell action potential
2.08E-02
SCN3B
depolarization
GO ID
Molecular Function Description
p-value
DEGs
GO:0017080
sodium channel regulator activity
5.51E-03
SCN3B;SGK1
GO:0086006
voltage-gated sodium channel activity involved in
1.49E-02
SCN3B
GO:0019871
sodium channel inhibitor activity
2.38E-02
SCN3B
cardiac
muscle
cell
action
potential
GO:0004861
cyclin-dependent protein serine/threonine kinase
2.96E-02
CDKN1A
GO:0061665
SUMO ligase activity
2.96E-02
EGR2
inhibitor
activity
GO:0017081
chloride channel regulator activity
4.41E-02
SGK1
GO:0004129
cytochrome-c oxidase activity
4.41E-02
COX4I2
GO:0051371
muscle alpha-actinin binding
4.41E-02
PDLIM1
GO:0031625
ubiquitin protein ligase binding
4.53E-02
CDKN1A;EGR2;ISG15
GO:0010314
phosphatidylinositol-5-phosphate binding
4.70E-02
PLEKHF1
Note. Using EnrichR, differentially regulated gene lists were evaluated for significant enrichment against the following gene set libraries: GO
Biological Process, GO Molecular Function (all from http://www.geneontology.org). The top 10 enriched terms were selected and ranked based
upon the combined score that was calculated by the EnrichR platform following Z-score permutation background correction on the Fisher exact
test p-value. Results were filtered for p < 0.05. Upregulated genes in red and downregulated genes in blue.
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Table 2.2 Gene Ontology of differentially expressed genes in the PVN of emulsifier treated mice
PVN- CMC vs Water
GO ID
Biological Process Description
GO:0090209
negative regulation of triglyceride metabolic process
GO:0045601
regulation of endothelial cell differentiation
GO:0048660
regulation of smooth muscle cell proliferation
GO:0010613
positive regulation of cardiac muscle hypertrophy
GO:0046887
positive regulation of hormone secretion
GO:0051004
regulation of lipoprotein lipase activity
GO:0051055
negative regulation of lipid biosynthetic process
GO:0010611
regulation of cardiac muscle hypertrophy
GO:0055090
acylglycerol homeostasis
GO:0070328
triglyceride homeostasis
GO ID
Molecular Function Description
GO:0016615
malate dehydrogenase activity
GO:0005179
hormone activity
GO:0031434
mitogen-activated protein kinase kinase binding
GO:0035259
glucocorticoid receptor binding
GO:0008140
cAMP response element binding protein binding
GO:0035497
cAMP response element binding
GO:0055102
lipase inhibitor activity
PVN- P80 vs Water
GO ID
Biological Process Description
GO:0007616
long-term memory
GO:0046329
negative regulation of JNK cascade
GO:0048660
regulation of smooth muscle cell proliferation
GO:0007614
short-term memory
GO:1903208
negative regulation of hydrogen peroxide-induced neuron death
GO:2000253
positive regulation of feeding behavior
GO:1903749
positive regulation of establishment of protein localization to
GO:0015820
leucine transport
mitochondrion
GO:0061469
regulation of type B pancreatic cell proliferation

p-value
9.88E-05
2.36E-04
2.81E-04
9.88E-04
1.22E-03
1.35E-03
1.48E-03
1.76E-03
1.91E-03
2.94E-03
p-value
1.55E-02
1.76E-02
2.06E-02
2.32E-02
2.32E-02
2.57E-02
2.57E-02
p-value
2.34E-03
6.97E-03
1.49E-02
1.89E-02
1.89E-02
1.89E-02
1.92E-02
2.26E-02
2.26E-02

DEGs
APOC3;SIK1
ATOH8;APOLD1
EDN1;NR4A3;TRIB1
EDN1;NR4A3
EDN1;GRP
ANGPTL8;APOC3
APOC3;SIK1
EDN1;NR4A3
ANGPTL8;APOC3
ANGPTL8;APOC3
DEGs
ME3
EDN1;GRP
TRIB1
NR4A3
SIK1
NR4A3
APOC3
DEGs
NPAS4;SGK1
PER1;HIPK3
NR4A3;TRIB1
NPAS4
NR4A3
NR4A3
PMAIP1;RHOU
SLC6A17
NR4A3
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GO:2000323
negative regulation of glucocorticoid receptor signaling pathway
2.26E-02
PER1
GO ID
Molecular Function Description
p-value
DEGs
GO:0051998
protein carboxyl O-methyltransferase activity
2.26E-02
PCMTD2
GO:0031995
insulin-like growth factor II binding
2.63E-02
IGFBP2
GO:0031434
mitogen-activated protein kinase kinase binding
3.00E-02
TRIB1
GO:0035259
glucocorticoid receptor binding
3.37E-02
NR4A3
GO:0035497
cAMP response element binding
3.74E-02
NR4A3
GO:0046975
histone methyltransferase activity (H3-K36 specific)
4.10E-02
PRDM9
GO:0070679
inositol 1,4,5 trisphosphate binding
4.10E-02
CYTH2
GO:0070513
death domain binding
4.10E-02
DAPL1
GO:0031994
insulin-like growth factor I binding
4.83E-02
IGFBP2
Note. Using EnrichR, differentially regulated gene lists were evaluated for significant enrichment against the following gene set libraries: GO
Biological Process, GO Molecular Function (all from http://www.geneontology.org). The top 10 enriched terms were selected and ranked based
upon the combined score that was calculated by the EnrichR platform following Z-score permutation background correction on the Fisher exact
test p-value. Results were filtered for p < 0.05. Upregulated genes in red and downregulated genes in blue.
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Enriched Pathways
To gain a mechanistic understanding of the altered gene expression observed during

emulsifier consumption, we next performed bioinformatic analysis using
INGENUITY® Pathway Analysis (IPA) to examine the biological relevance of altered gene
pathways using a systems biology approach. Genes imported into IPA had a stringency filter set
for statistically significant genes (fold-change >1, adj p-value < 0.05) within the amygdala and
PVN of emulsifier vs water controls. The top 5 canonical pathways (CPs) are presented in Table
2.3. These analyses revealed sets of genes within the amygdala and PVN tissue that were highly
enriched in primarily immune-related canonical pathways. Interestingly, though both CMC and
P80 conditions resulted in enriched immune-related pathways within the amygdala and PVN,
neither condition had a common pathway shared. Among CMC-treated animals, the top
dysregulated canonical pathways in the amygdala were MIF regulation of innate immunity (p =
9.47E-05), corticotropin-releasing hormone (CRH) signaling (p = 2.45E-04), Coronavirus
pathogenesis pathway (p = 2.79E-04), CD40 signaling (p = 3.48E-04), and ILK signaling (p =
6.81E-04). Within the PVN, the top canonical pathways included opioid signaling pathway (p =
4.14E-06), G-protein coupled receptor signaling (p = 8.10E-05), CRH signaling (p =9.13E-05),
CREB signaling in neurons (p = 1.95E-04), and CDK5 signaling (p = 2.19E-04). Figure 2.5
depicts the IPA predicted molecular interactions of DEGs within the CRH pathway.
Functionally, glucocorticoid synthesis may be Nur77/Nr4a1 dependent and pro-inflammatory
prostaglandin synthesis may be COX2 dependent within the canonical CRH pathway. Among
P80-treated animals, the top dysregulated canonical pathways in the amygdala were IL-17A
signaling in gastric cells (p = 1.08E-03), T-cell receptor signaling (p = 1.39E-03), CD28
signaling in T-helper cells (p =1.67E-03), TNFR2 signaling (p =1.84E-03), and IL-17A signaling
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in fibroblasts (p = 2.22E-03). Within the PVN, the top canonical pathways included role of JAK2
in hormone-like cytokine signaling (p = 6.22E-04), opioid signaling pathway (p = 1.52E-03),
role of Wnt/GSK-3 signaling in the pathogenesis of Influenza (p =4.63E-03), human embryonic
stem cell pluripotency (p =5.02E-03), and role of JAK1 and JAK3 in cytokine signaling (p
=5.49E-03). In addition, analysis of significant disease pathways in IPA showed considerable
overlap between emulsifier conditions but also showed regional differences that likely reflect the
region-specific response to emulsifier treatment (Figure 2.6). Altogether, these results
demonstrate that CMC and P80 consumption induces limited but physiologically relevant
alterations in gene expression in brain regions controlling physiological and behavioral
concomitants of stress and anxiety.
Table 2.3 Top five IPA enriched canonical pathways of differentially expressed genes in
the amygdala and PVN of emulsifier treated mice.
Top Canonical Pathways
Amygdala- CMC vs Water
Name

p-value

Overlap

MIF Regulation of Innate Immunity

9.47E-05

7.1% 3/42

Corticotropin Releasing Hormone Signaling

2.45E-04

2.8% 4/145

Coronavirus Pathogenesis Pathway

2.79E-04

2.7% 4/150

CD40 Signaling

3.48E-04

4.6% 3/65

ILK Signaling

6.81E-04

2.1% 4/190

p-value

Overlap

IL-17A Signaling in Gastric Cells

1.08E-03

8.7% 2/23

T Cell Receptor Signaling

1.39E-03

2.9% 3/104

CD28 Signaling in T Helper Cells

1.67E-03

2.7% 3/111

TNFR2 Signaling

1.84E-03

6.7% 2/30

IL-17A Signaling in Fibroblasts

2.22E-03

6.1% 2/33

Amygdala- P80 vs Water
Name
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PVN- CMC vs Water
Name

p-value

Overlap

Opioid Signaling Pathway

4.14E-06

3.8% 9/236

G-Protein Coupled Receptor Signaling

8.10E-05

3.0% 8/267

Corticotropin Releasing Hormone Signaling

9.13E-05

4.3% 6/139

CREB Signaling in Neurons

1.95E-04

1.9%

CDK5 Signaling

2.19E-04

4.8% 5/104
11/570

PVN- P80 vs Water
Name
Role of JAK2 in Hormone-like Cytokine
Opioid Signaling Pathway
Signaling
Role of Wnt/GSK-3 Signaling in the
Human
Pathogenesis
of Embryonic
Influenza Stem Cell Pluripotency
Role of JAK1 and JAK3 in c Cytokine Signaling

p-value

Overlap

6.22E-04

9.4% 3/32

1.52E-03

2.5% 6/236

4.63E-03

4.7% 3/64

5.02E-03

3.1% 4/131

5.49E-03

4.4% 3/68

Note. Emulsifier-treatment is primarily associated with inflammation and other immune-related canonical
pathways. The top categories were ranked in accordance with their P-value of overlap. Overlap refers to
the number of molecules from the dataset that map to the pathway listed divided by the total number of
molecules that define the canonical pathway from within the IPA knowledgebase.

COX2

Figure 1. Canonical pathway (Modified from IPA) for Opioid Signaling [−log(P-value) = 8.48; Z-score = 0.392].

Downloaded from https://academic.oup.com/jas/article-abstract/98/1/skz368/5661111 by KERIS National Access, bpl103@msstate.edu on 24 January 2020
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Figure 2.5 Corticotropin-Releasing Hormone Pathway Identified by Ingenuity Pathway
Membrane Hyperpolarization and Receptor Internalization, but
Analysis
decreased Neurotransmission, Membrane Potential, Synaptic

Chefer et al., 2005). Therefore, the predicted repression of the
KOR-mediated opioid pathway coincides with activation of
both the Dopamine Receptor Signaling and Dopamine-DARPP32
Feedback in cAMP Signaling pathways (Table 1). With regard to
the opioid signaling pathway, IPA software predicted increased

Note. The CRH pathway is identified as one of
the significant
pathways
byPNSIPA
within
Transmission,
and Analgesic
Tolerance in
compared
withthe PVN of CMCControl
bulls (Figure
1). Alterations
various
components
the pink and overlaid
treated animals (p= 9.13E-05). All up-regulated
DEGs
in our
datasettoare
shown
hereofin
opioid signaling pathway have been reported to be influenced by
onto the CRH molecular pathway.
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Figure 2.6 Top enriched IPA disease pathways
Note. Top diseases in the amygdala after CMC treatment (a) or P80 treatment (b) and PVN after CMC
treatment (c) or P80 treatment (d). Threshold indicates minimum significance level [–log (p-value) from
Fisher’s exact test].
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Validation of RNA-Seq results by quantitative real-time PCR (qRT-PCR)
Six DEGs were selected due to their involvement in stress responding and immune

function according to previous studies. SGK1, NR4A3, PRRC2A, FOSB, PTGS2, and EGR2
were selected to validate RNA-Seq results by qRT-PCR (Table 2.4). Expression levels
calculated via RNA-Seq were significantly positively correlated to expression levels determined
via qRT-PCR (Figure 2.7; R2=0.8815, p<0.0001). For all genes tested, qRT-PCR data strongly
correlate with RNA-Seq data except for PTGS2 expression levels within the PVN. Expression
levels of PTGS2 measured by qRT-PCR were higher than indicated by RNA-Seq expression.
Overall, the correlation observed between qRT-PCR and RNA-seq further strengthens the
emulsifier-induced alteration in gene expression described above, validating the RNA-seq
approach on punched brain regions to investigate the impact of altered host/microbiota
relationship on the central nervous system.
Table 2.4 List of primer sequences used for qRT-PCR.
qRT-PCR Primers
Gene

Forward-sequence

Reverse-sequence

Sgk1

TCCTGAGGTCCTCCATAAGCA

GTGCCTTGCCGAGTTTGTAAT

Nr4a3

TTCTGACGGCCTCCATTGAC

CTCCCCAAATCCTCGAAGGC

Prrc2a

GGACTCTGCCGGGGTTAAT

AGAAGACCTCAGGGTACGGA

Fosb

GCCAGGAACCAGCTACTCAA

CTTGTTCCGCTCTCTGCGAA

Ptgs2

CTGACCCCCAAGGCTCAAAT

TCTGCTCTGGTCAATGGAGG

Egr2

GCCGTAGACAAAATCCCAGT

AGCTACTCGGATACGGGAGA

Ywhaz

GATCCCCAATGCTTCGCAAC

CCAGTCTGATGGGGTGTGTC
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Figure 2.7 Validation of RNA-Sequencing results by quantitative RT-PCR.
Note. Log2 fold change correlation between RNA-Seq and quantitative real-time PCR (qRT-PCR) for six
differentially expressed genes (SGK1, NR4A3, PRRC2A, FOSB, PTGS2, EGR2; n=5) within Amygdala
CMC, Amygdala P80, PVN CMC, and PVN P80 conditions. Correlation between RNA-Seq and qRTPCR gene expression (R2=0.8815, p<0.0001).

2.2.6

Consumption of dietary emulsifiers does not result in dehydration
One potential confounding factor that could drive gene expression changes in the current

study is changes in hydration[22] among groups if the emulsifiers altered water intake or
absorption. To eliminate the possibility that gene changes were secondary to changes in
hydration rather than to the emulsifier treatment, itself, various hydration measures were
compared between emulsifier-treated animals and water controls. Measures included liquid
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intake, plasma osmolarity, and a hydration ratio obtained by echo magnetic resonance imaging
(eMRI). There were no significant differences in liquid intake between groups (CMC vs water,
p=.86 and P80 vs water, p=.19) over 3 days at the end of the treatment phase of the study
(Figure 2.8.a). Additionally, neither the hydration ratio of CMC (p=.47) nor P80 (p=.12)
differed significantly from water-treated controls (Figure 2.8.b). There were no significant
differences in plasma osmolarity, a measure of hydration status, between groups (CMC vs water,
p=.78 and P80 vs water, p=.52) (Figure 2.8.c). Altogether, all three hydration measures indicate
that emulsifier treatment does not result in changes in liquid intake, dehydration, or changes in
body composition, thus this is unlikely to be a confounding factor driving differential gene
expression seen in emulsifier conditions versus control.
Liquid Intake
(Over 3 Days)

b

eMRI Hydration Ratio
(Total Water- Free Water/ Lean Mass)

100

20

80

15

60

ml

%

25

10

40

5

20

Water CMC P80

Plasma Osmolarity
400
300
200
100
0

0

0

c

mOsmo/Kg H2O

a

WaterCMC P80

Water CMC P80

Figure 2.8 Hydration measures
Note. There were no differences among groups in liquid intake (a), hydration ratio as measured by eMRI
(b), or plasma osmolarity (c). N=10 in each group.

2.3

Discussion
The present study tested the hypothesis that emulsifier intake, at doses that are directly

relevant to those ingested by humans, can influence gene expression in brain regions that are
known to be important in the generation of behavioral and neuroendocrine responses to stress-
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provoking stimuli. The current findings illustrate the novel finding that emulsifier consumption
induces genetic alternations within the amygdala and PVN that could be associated with the
previously reported anxiety-like phenotype[7]. It appears that emulsifier treatment increased
expression of IEGs such as NR4A2, NR4A3, EGR2, JUNB, FOSB, and FOSL2 in the amygdala
and PVN, suggesting that both CMC and P80 may increase neuronal activity in brain regions that
modulate stress responding. Because no additional procedures were experienced by the animals
before euthanasia, the increase in IEGs suggests that the emulsifiers may have increased
sensitivity to the mild stress of transport and handling that occurred just before tissue collection.
Increased neural activity in the amygdala and PVN is associated with an anxiety-like
phenotype in rodents and may thus be brain regions within which emulsifiers act to increase
anxiety-like behavior[23]. Further, differential expression of multiple HPA axis regulatory and
responsive genes in emulsifier-treated animals indicates possible dysregulation of the HPA axis.
Analysis of gene ontology shows emulsifier-induced alterations in the function of
“glucocorticoid receptor binding” in both CMC and P80 conditions. NR4A2, NR4A3, and SGK1
are known to code for proteins that regulate glucocorticoid receptor function, and all three of
these showed increased differential expression in emulsifier-treated animals. NR4A2 (NURR1)
and NR4A3 (NOR1) are immediate early genes induced by growth factors, inflammatory signals,
and glucocorticoids and are known to regulate the HPA axis at the hypothalamic, pituitary, and
adrenal level [24, 25]. In addition, we found emulsifier-treated animals had decreased expression
of PCLO and increased expression of SGK1, which are known biomarkers of clinical depression,
a disorder often characterized by HPA axis dysregulation. More specifically, decreased
expression of PLCO is associated with increased activity in the amygdala of depressed
patients[26]. Increased expression of SGK1, a glucocorticoid receptor (GR)-inducible gene, is
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found in the hypothalamus and the serum of patients with depression[20]. SGK1 is known to
prolong GR activation[27], which makes this gene a prime, potential molecular mechanism by
which emulsifiers may sensitize the stress response.
Neuroinflammation is another possible mechanism by which emulsifier consumption
may alter behavior. It is previously established that emulsifier consumption causes low-grade
inflammation in the periphery[6, 28]. The present study is the first to provide evidence that
emulsifiers may cause immune activity centrally, as well. The top enriched canonical pathways
in emulsifier-treated animals were largely comprised of altered immune pathways in both the
amygdala and PVN. These potential changes in central immune activation are highly relevant, as
increased neuroinflammation is proposed to be a driving factor in the expression of anxiety and
depression-like behavior[29]. Indeed, recent studies have demonstrated that decreasing innate
immune system activity ameliorates social defeat-induced social anxiety and depression in mice
[29]. One immune DEG of high interest that increased in the amygdala as a result of emulsifier
consumption was PTGS2 (COX2), a gene responsible for coding the enzyme that converts
arachidonic acid to pro-inflammatory prostaglandins. Other studies show that increased COX2
expression in the brain increases susceptibility to chronic mild unpredictable stress in rats, and
COX2 inhibition decreases anxiety-like behavior in mice and decreases glutamatergic activity in
the amygdala[30, 31]. Taken together, Cox-2 may be another prime mechanistic candidate
driving emulsifier-induced stress sensitivity. Further connecting neuro- inflammation to stress
sensitivity, the top canonical pathway identified in the amygdala of CMC-treated mice was “MIF
Regulation of Innate Immunity”. Macrophage migration inhibitory factor (MIF) is released from
immune cells in response to infectious stimuli and is also considered an endocrine hormone
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capable of participating in HPA axis regulation[32]. Moreover, MIF is highly expressed in the
brain and plays a key role in anxiety- and depression-like behaviors[33, 34].
It is important to note that both blood and vasculature were likely present in our brain
samples. Several genes expressed in vasculature endothelial cells were found to be altered in the
PVN and amygdala of emulsifier-treated animals and are known to play a role in blood-brain
barrier function. Decreased expression of PCDHGA5, the gene that codes for a cadherin-like
adhesion protein, was found in the PVN of CMC-treated mice. This gene plays a critical role in
the barrier-stabilization properties of the blood-brain barrier (BBB)[35]. Decreased expression of
this gene may indicate compromised vasculature within the brain. In addition, increased
expression of ARNO (cytohesion-2) was found in the PVN of P80-treated mice. This gene plays
a critical role in the permeability of the BBB. Increased expression of ARNO is associated with
increased vessel permeability[36]. Lastly, increased expression of SPARC was found in the
amygdala of CMC-treated mice. Pro-inflammatory molecules are known to increase SPARC
expression in endothelial cells. SPARC alters BBB properties through increased paracellular
permeability and decreased transendothelial electrical resistance (TEER)[37]. The presence of
these genes is of particular interest as both neuroinflammation and BBB dysfunction are
implicated in the neurobiology of stress-related disorders, namely, major depressive
disorder[38].
A limitation to this study is the exclusion of females from our dataset. Due to the high per
sample cost of RNA-seq, only males were included in this study. Diet-induced inflammation
may have sex-specific effects on gene expression in areas of the brain critical for stress
responding, such as the amygdala and PVN [39]. The exclusion of females from this study is a
clear limitation, as sex differences in the prevalence of both inflammatory disease and stress-
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related disorders exist in the clinical population[40, 41]. A critical future direction will be to
investigate sex differences in emulsifier-induced gene expression in brain regions critical for the
modulation of the stress response [7, 42]. Another consideration is the fact that the 1 mm tissue
punches of PVN and amygdala clearly captured several distinct subregions. Therefore, the DEGs
captured here are summative of these heterogeneous regions. Future studies could use single-cell
RNA-Seq to examine DEGs in identified cell groups.
In conclusion, these data are the first to show that chronic emulsifier ingestion, known to
be associated with microbiota alterations and low-grade inflammation, induced altered gene
expression in key areas of the brain that control stress-related behavior. The transcripts and
pathways highlighted here provide a more concrete understanding of the molecular mechanisms
by which emulsifier consumption may affect HPA-axis functioning and stress-associated
behaviors. Future experiments will test the extent to which emulsifiers sensitize behavioral and
neuroendocrine stress responding, specifically assessing the role of the discussed DEGs in
driving these phenotypes. Ultimately, the data obtained from this project highlight potential
molecular neural mechanisms by which food additives, like emulsifiers, may affect inflammatory
processes and behavior.
2.4

Methods

2.4.1

Animals
Adult male C57BL/6J mice, 8 weeks of age (The Jackson Laboratory, Bar Harbor, ME),

were group-housed (5 mice per cage) in ventilated OptiMouse plastic cages with AlphaDri
bedding. Mice were maintained on a 12:12 hour light/dark cycle, and food and water were
supplied ad libitum. All procedures were approved by and performed in accordance with the
guidelines of the Institutional Animal Care and Use Committee (IACUC) at Georgia State
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University and with national regulations and policies. This study was performed in accordance
with Animals in Research: Reporting In Vivo Experiments (ARRIVE) guidelines.
2.4.2

Procedure
Mice (n=5/group) received drinking water containing either 1% sodium

carboxymethylcellulose (CMC; Sigma, St. Louis, MO ), 1% polysorbate-80 (P80; Sigma), or
water without an emulsifier, a control group. Our previous work has shown that similar
inflammatory and metabolic changes occur following emulsifiers administered in either food or
water [6]. Body weights were measured throughout the duration of the study. After 12 weeks of
respective emulsifier or control treatment, animals were removed from their home cage,
immediately anesthetized with isoflurane, and then decapitated. Brains were rapidly extracted,
flash-frozen in ice-cold isopentane, and then stored at -80˚C until sectioning. Fat-pads, colons,
and spleens were also collected for analysis of weight or length (colon).
2.4.3

RNA extraction
Brains were sectioned coronally at 300 µm on a cryostat and bilateral 1mm tissue

punches were taken of the central/basolateral amygdala and the PVN. For RNA-seq and realtime, quantitative polymerase chain reaction (RT-qPCR), total RNA was extracted from tissue
punches using a Trizol extraction method as described earlier [6]. In brief, brain tissue was
homogenized in Trizol, followed by the addition of chloroform, and then centrifuged to separate
the RNA aqueous layer from other cell contents. RNA was then alcohol-precipitated and
resuspended in 30 µl nuclease-free water. RNA concentration and purity were measured using a
nanodrop spectrophotometer, and the two samples from each group with the highest
concentration and purity were sent for Illumina sequencing as described below.
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mRNA sequencing library preparation
Total RNA extracted from the bilateral amygdala and PVN punches of animals treated

with either CMC, P80, or emulsifier-free drinking water (N=2/group) were used to create mRNA
sequencing libraries. Our initial study used a small number of samples taken from individual
animals to maximize the number of group comparisons, while still allowing for the statistical
identification of possible differentially expressed genes that could be subsequently validated with
quantitative PCR using a larger group of animals [43, 44]. The mRNA sequencing library was
constructed using the TruSeq RNA Sample Preparation kit (Illumina, San Diego, CA) following
the manufacturer’s instructions. In brief, PolyA-containing mRNAs were purified using oligodT attached magnetic beads followed by RNA fragmentation. cDNA was synthesized from
RNA primed with random hexamers using reverse transcriptase. 3' overhangs and 5' overhangs
were repaired using End Repair Mix. After adenylation of the 3’ end, indexing adaptors are
added to cDNA in preparation to be hybridized onto a flow cell. PCR was performed with a PCR
Primer Cocktail that selectively amplifies DNA fragments with adaptors.
2.4.5 Sequencing
Each sample was uniquely indexed (barcoded) to allow for the pooling of all samples in a
single sequencing run. A 75-cycle sequencing run was performed on the Illumina NextSeq 500
at the Genomics Core at Cornell University (Ithaca, NY). Data were processed using the
standard Illumina processing pipeline to segregate each multiplexed samples’ reads. The
resulting data files were in fastq format and included at least 20 million reads per sample.
2.4.6 Analysis Pipeline
Various programs were used to assess sequence quality, determine differential gene
expression, and perform ontological and pathway analysis. The FastQC program
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(https://www.bioinformatics.babraham.ac.uk/projects/fastqc/) was used to assess the quality of
reads and to provide various statistics such as total reads, total sequences, GC content, and
sequence duplication levels. GC content for each sample fit the theoretical distribution, thus
indicating no contamination or systemic bias within the samples. FASTQ quality filter
(http://hannonlab.cshl.edu/fastx_toolkit/commandline.html#fastq_quality_filter_usage) was used
to filter low-quality sequences (base quality score less than 30) leaving only sequences with
high-quality scores. High-quality reads were then aligned to mm10 mus musculus reference
genome using Bowtie2 and Tophat2 to identify gene sequences[45]. Gene expression levels were
measured using Cufflinks and differential expression was measured using Cuffdiff [46].
Fragments Per Kilobase of transcript per Million mapped reads (FPKM) expression scores were
obtained for each gene. Log2fold differential expression scores for each gene are calculated by
dividing the average FPKM score for each experimental group by the average FPKM score for
the water control group and converting the fold change to a logarithmic 2 scale after which a pvalue was calculated[47]. P-score values were FDR adjusted (q-value) using the BenjaminiHochberg correction [48]. Only genes that had an adjusted p-score value (q-value) < 0.05 and at
least a log2fold score of 1 and -1, which are widely accepted cutoffs, were used for subsequent
analysis[49]. Lastly, EnrichR and Ingenuity Pathway Analysis (QIAGEN Inc.,
https://digitalinsights.qiagen.com/IPA) were used to perform gene set enrichment and to analyze
DEGs to predict significant canonical pathways and diseases. Overlap with canonical pathways
were based on well-established metabolic and signaling pathways that are within the
INGENUITY knowledgebase, and enrichment for diseases were based on the annotations for
diseases and disorders in the IPA curated knowledgebase. The Fisher's Exact Test was used to
calculate the statistical significance of the overlap of DEG. R was used to generate expression
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heat maps using the heatmap.2 function from the ggplot2 library and volcano plots were
generated using in-house scripts.
2.4.7

RT-qPCR validation
Six genes of interest that were observed to be differentially expressed in the RNA-Seq

dataset were selected for further RT-qPCR validation. Animals (n=5/group) were treated as
described in Experiment 1 (RNA-Seq) and then gene expression was measured in the amygdala
and PVN. In brief, RNA from tissue punches of the amygdala and PVN was synthesized into
cDNA using a SuperScript IV First Stand Synthesis System to manufacture’s specifications.
Primers for genes of interest were designed using the NCBI primer design tool and only
sequences that were exclusively specific to the gene of interest were used. Primer efficiency and
specificity were verified; primer sequences are listed in Supplementary Table 1. cDNA was
amplified using primers and Quantifast SYBR green PCR reaction mix via real-time PCR to
allow for quantification of total gene expression. PCR cycle conditions were 95˚C for five
minutes then 40 amplification cycles of 95˚C for 10 seconds to denature and 60˚C for 30 seconds
to anneal and elongate. A melting curve was run for each primer to verify the formation of only
one product. Data were normalized to the well-validated housekeeping gene, YWHAZ using the
ΔΔct method because previous research has shown that YWHAZ expression remains stable
under inflammatory conditions[50], and we verified that it did not vary by condition in this
study. RT-qPCR relative gene expression within each brain region was compared between
emulsifier and water control groups.
2.4.8

Hydration measures
2.4.8.1 Liquid intake. To verify that the emulsifier treatment did not alter the volume of

liquid ingested, liquid intake was measured in an additional cohort of animals (N=10/group) that
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were also treated as in Experiment 1 (RNA-Seq). Thus, after 12-weeks of emulsifier or control
treatment, animals were singly housed to determine the volume ingested by each individual over
a 72 hr period. Mice were given a 50ml sipper tube filled with respective emulsifier or water.
Volume within the sipper bottle was logged daily for 3 consecutive days to determine the total
ml of fluid ingested.
2.4.8.2 Echo Magnetic Resonance Imaging (eMRI). In addition to the liquid intake
measures, the body composition of each subject was measured using an EchoMRI 1100
(EchoMRI LLC, Houston, TX, USA) to determine whether emulsifier intake altered body
composition or hydration compared to that observed in mice drinking only water with no
emulsifier added. Briefly, animals were weighed and inserted into the eMRI restrainer tube. The
tube was then inserted into the eMRI machine and body composition was measured. This
procedure is non-invasive and does not require the use of anesthesia. Tubes were disinfected
with 70% ethanol between testing each mouse. Parameters were measured in triplicate with each
measure lasting approximately 30 seconds. Measures collected included body mass, total body
fat, lean body mass, free water, and total body water content. A hydration ratio was obtained by
using the following equation: (total water – free water/ lean mass).
2.4.8.3 Plasma Osmolarity. Immediately after the completion of eMRI measures,
animals were sacrificed by decapitation and trunk blood was collected in heparinized tubes.
Blood was spun down immediately in a refrigerated microcentrifuge at 1,500 x G for 10 minutes.
The plasma layer was isolated and plasma osmolality was quantitatively determined using the
Advanced Instruments Model 3300 Micro-Osmometer (Advanced Instruments, Norwood, MA,
USA) according to the manufacturer’s instructions.

CONSUMPTION OF DIETARY EMULSIFIERS
2.5
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.

45

References
Miller, A.H., Beyond depression: the expanding role of inflammation in psychiatric
disorders. World Psychiatry, 2020. 19(1): p. 108-109.
Kim, J., et al., A double-hit of stress and low-grade inflammation on functional brain
network mediates posttraumatic stress symptoms. Nat Commun, 2020. 11(1): p. 1898.
Haroon, E., C.L. Raison, and A.H. Miller, Psychoneuroimmunology meets
neuropsychopharmacology: translational implications of the impact of inflammation on
behavior. Neuropsychopharmacology, 2012. 37(1): p. 137-62.
Slavich, G.M. and M.R. Irwin, From stress to inflammation and major depressive
disorder: a social signal transduction theory of depression. Psychol Bull, 2014. 140(3): p.
774-815.
Berk, M., et al., So depression is an inflammatory disease, but where does the
inflammation come from? Bmc Medicine, 2013. 11.
Chassaing, B., et al., Dietary emulsifiers impact the mouse gut microbiota promoting
colitis and metabolic syndrome. Nature, 2015. 519(7541): p. 92-6.
Holder, M.K., et al., Dietary emulsifiers consumption alters anxiety-like and socialrelated behaviors in mice in a sex-dependent manner. Sci Rep, 2019. 9(1): p. 172.
Viennois, E., et al., Dietary Emulsifier-Induced Low-Grade Inflammation Promotes
Colon Carcinogenesis. Cancer Res, 2017. 77(1): p. 27-40.
DeMorrow, S., Role of the Hypothalamic-Pituitary-Adrenal Axis in Health and Disease.
Int J Mol Sci, 2018. 19(4).
Silverman, M.N., et al., Immune modulation of the hypothalamic-pituitary-adrenal (HPA)
axis during viral infection. Viral Immunol, 2005. 18(1): p. 41-78.
Farzi, A., E.E. Frohlich, and P. Holzer, Gut Microbiota and the Neuroendocrine System.
Neurotherapeutics, 2018. 15(1): p. 5-22.
de Punder, K. and L. Pruimboom, Stress induces endotoxemia and low-grade
inflammation by increasing barrier permeability. Front Immunol, 2015. 6: p. 223.
Ait-Belgnaoui, A., et al., Prevention of gut leakiness by a probiotic treatment leads to
attenuated HPA response to an acute psychological stress in rats.
Psychoneuroendocrinology, 2012. 37(11): p. 1885-95.
Fillman, S.G., et al., Markers of inflammation and stress distinguish subsets of
individuals with schizophrenia and bipolar disorder. Transl Psychiatry, 2014. 4: p. e365.
Menard, C., et al., Immune and Neuroendocrine Mechanisms of Stress Vulnerability and
Resilience. Neuropsychopharmacology, 2017. 42(1): p. 62-80.
Chen, E.Y., et al., Enrichr: interactive and collaborative HTML5 gene list enrichment
analysis tool. BMC Bioinformatics, 2013. 14: p. 128.
Kuleshov, M.V., et al., Enrichr: a comprehensive gene set enrichment analysis web server
2016 update. Nucleic Acids Res, 2016. 44(W1): p. W90-7.
Xie, Z., et al., Gene Set Knowledge Discovery with Enrichr. Curr Protoc, 2021. 1(3): p.
e90.
Murphy, E.P. and O.M. Conneely, Neuroendocrine regulation of the hypothalamic
pituitary adrenal axis by the nurr1/nur77 subfamily of nuclear receptors. Mol Endocrinol,
1997. 11(1): p. 39-47.

CONSUMPTION OF DIETARY EMULSIFIERS
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.

46

Anacker, C., et al., Role for the kinase SGK1 in stress, depression, and glucocorticoid
effects on hippocampal neurogenesis. Proc Natl Acad Sci U S A, 2013. 110(21): p. 870813.
Dattilo, V., et al., The Emerging Role of SGK1 (Serum- and Glucocorticoid-Regulated
Kinase 1) in Major Depressive Disorder: Hypothesis and Mechanisms. Front Genet,
2020. 11: p. 826.
Watts, A.G., G. Sanchez-Watts, and A.B. Kelly, Distinct patterns of neuropeptide gene
expression in the lateral hypothalamic area and arcuate nucleus are associated with
dehydration-induced anorexia. J Neurosci, 1999. 19(14): p. 6111-21.
Singewald, N., Altered brain activity processing in high-anxiety rodents revealed by
challenge paradigms and functional mapping. Neurosci Biobehav Rev, 2007. 31(1): p.
18-40.
Murphy, E.P., et al., Involvement of the nuclear orphan receptor NURR1 in the
regulation of corticotropin-releasing hormone expression and actions in human
inflammatory arthritis. Arthritis Rheum, 2001. 44(4): p. 782-93.
Helbling, J.C., et al., Stress and glucocorticoid regulation of NR4A genes in mice. J
Neurosci Res, 2014. 92(7): p. 825-34.
Kuehner, C., et al., PCLO rs2522833 impacts HPA system activity in healthy young
adults. Transl Psychiatry, 2011. 1: p. e10.
Lang, F., et al., Significance of SGK1 in the regulation of neuronal function. J Physiol,
2010. 588(Pt 18): p. 3349-54.
Chassaing, B., et al., Dietary emulsifiers directly alter human microbiota composition and
gene expression ex vivo potentiating intestinal inflammation. Gut, 2017. 66(8): p. 14141427.
Nie, X., et al., The Innate Immune Receptors TLR2/4 Mediate Repeated Social Defeat
Stress-Induced Social Avoidance through Prefrontal Microglial Activation. Neuron,
2018. 99(3): p. 464-479 e7.
Chen, Q., et al., Cyclooxygenase-2 Signalling Pathway in the Cortex is Involved in the
Pathophysiological Mechanisms in the Rat Model of Depression. Sci Rep, 2017. 7(1): p.
488.
Morgan, A., et al., Cyclooxygenase-2 inhibition reduces anxiety-like behavior and
normalizes enhanced amygdala glutamatergic transmission following chronic oral
corticosterone treatment. Neurobiol Stress, 2019. 11: p. 100190.
Calandra, T. and R. Bucala, Macrophage Migration Inhibitory Factor (MIF): A
Glucocorticoid Counter-Regulator within the Immune System. Crit Rev Immunol, 2017.
37(2-6): p. 359-370.
Conboy, L., et al., Macrophage migration inhibitory factor is critically involved in basal
and fluoxetine-stimulated adult hippocampal cell proliferation and in anxiety, depression,
and memory-related behaviors. Mol Psychiatry, 2011. 16(5): p. 533-47.
Bacher, M., et al., MIF expression in the rat brain: implications for neuronal function.
Mol Med, 1998. 4(4): p. 217-30.
Dilling, C., et al., Multiple protocadherins are expressed in brain microvascular
endothelial cells and might play a role in tight junction protein regulation. J Cereb Blood
Flow Metab, 2017. 37(10): p. 3391-3400.
Zhu, W., et al., Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt
vascular stability. Nature, 2012. 492(7428): p. 252-5.

CONSUMPTION OF DIETARY EMULSIFIERS
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.

47

Alkabie, S., et al., SPARC expression by cerebral microvascular endothelial cells in vitro
and its influence on blood-brain barrier properties. J Neuroinflammation, 2016. 13(1): p.
225.
Najjar, S., et al., Neurovascular unit dysfunction with blood-brain barrier
hyperpermeability contributes to major depressive disorder: a review of clinical and
experimental evidence. J Neuroinflammation, 2013. 10: p. 142.
McCann, K.E., et al., Transcriptomic Analysis Reveals Sex-Dependent Expression
Patterns in the Basolateral Amygdala of Dominant and Subordinate Animals After Acute
Social Conflict. Mol Neurobiol, 2019. 56(5): p. 3768-3779.
Bromet, E., et al., Cross-national epidemiology of DSM-IV major depressive episode.
BMC Med, 2011. 9: p. 90.
Hayter, S.M. and M.C. Cook, Updated assessment of the prevalence, spectrum and case
definition of autoimmune disease. Autoimmun Rev, 2012. 11(10): p. 754-65.
Elderman, M., P. de Vos, and M. Faas, Role of Microbiota in Sexually Dimorphic
Immunity. Front Immunol, 2018. 9: p. 1018.
Zhang, Z.H., et al., A comparative study of techniques for differential expression analysis
on RNA-Seq data. PLoS One, 2014. 9(8): p. e103207.
Sugino, K., et al., Mapping the transcriptional diversity of genetically and anatomically
defined cell populations in the mouse brain. Elife, 2019. 8.
Langmead, B. and S.L. Salzberg, Fast gapped-read alignment with Bowtie 2. Nat
Methods, 2012. 9(4): p. 357-9.
Trapnell, C., et al., Differential gene and transcript expression analysis of RNA-seq
experiments with TopHat and Cufflinks. Nat Protoc, 2012. 7(3): p. 562-78.
Trapnell, C., et al., Transcript assembly and quantification by RNA-Seq reveals
unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol,
2010. 28(5): p. 511-5.
Reiner, A., D. Yekutieli, and Y. Benjamini, Identifying differentially expressed genes
using false discovery rate controlling procedures. Bioinformatics, 2003. 19(3): p. 368-75.
McDermaid, A., et al., Interpretation of differential gene expression results of RNA-seq
data: review and integration. Brief Bioinform, 2019. 20(6): p. 2044-2054.
Cinar, M.U., et al., Evaluation of suitable reference genes for gene expression studies in
porcine alveolar macrophages in response to LPS and LTA. BMC Res Notes, 2012. 5: p.
107.

CONSUMPTION OF DIETARY EMULSIFIERS

48

3 COX INHIBITION AMELIORATES SENSITIVITY TO SOCIAL STRESS IN
MICE THAT CONSUME DIETARY EMULSIFIERS
3.1

Introduction
Stress-related disorders are often characterized by enhanced immune activation and

dysregulation of the hypothalamic-pituitary-adrenocortical (HPA) axis, the main modulator of
the body’s neuroendocrine response to stress [1-4]. Chronic low-grade inflammation has been
identified as a factor that can potentiate stress responsivity and fuel the progression of
neuropsychiatric disorders [5, 6]. In addition, dietary components that disrupt the gastrointestinal
microbiome have recently been identified as an environmental factor that can underlie chronic
inflammatory conditions in clinical populations, and these components might thus increase
susceptibility to stress-related disorders [7, 8]. Emulsifying agents such as
carboxymethylcellulose (CMC) and polysorbate-80 (P80) are added to processed foods and
beverages to improve consistency and extend shelf-life. While these dietary components have
been deemed safe for consumption at low doses by the Food and Drug Administration, it has
recently been demonstrated that these additives can cause gut dysbiosis, promote systemic
inflammation, and alter immune and stress-related genes in the brain [8-11]. Recently, it was
also reported that animals fed emulsifiers at percent doses that are approved for human
consumption may show increased basal, anxiety-like behavior. However, it is not known whether
emulsifier consumption potentiates stress responding [10].
We have recently demonstrated via RNA-Seq that chronic emulsifier consumption results
in alterations in gene expression of various immediate early, stress-related, and immune-related
genes in brain regions that are known to be important in the generation of behavioral and
neuroendocrine responses to stress-provoking stimuli [11]. Increased neural activity, as indicated
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by increased expression of immediate early genes (IEGs) in stress-modulatory brain regions such
as the paraventricular nucleus and amygdala, is known to be associated with an anxiety-like
phenotype in rodents [12]. Further, differential expression of HPA axis regulatory genes and
altered expression of immune-related genes in the brain can contribute to an altered behavioral
and neuroendocrine stress response [13, 14]. Altogether, the neurogenetic profile of animals that
consume emulsifiers suggests that these animals might be hypersensitive to stressful stimuli.
Thus, the purpose of this project was to test the hypothesis that the consumption of emulsifiers
exacerbates stress responding and that it does so at least in part via increased neuro-immune
signaling. First, we examined whether the consumption of emulsifiers at doses the FDA
considers safe for humans enhances behavioral, neural activational, and hormonal responses to
an acute social defeat stressor.
Next, we evaluated the role of the COX inflammatory pathway as a mechanistic
candidate driving social stress sensitivity in mice that chronically consume dietary emulsifiers.
We previously reported that cyclo-oxygenase 2 (PTGS2/COX2), a gene responsible for coding
the enzyme that converts arachidonic acid to pro-inflammatory prostaglandins, increased in the
amygdala following emulsifier consumption [11]. Clinically, COX-2 activity may contribute to
the pathophysiology of stress-related psychiatric disorders given that peripheral COX-2
expression is increased in subpopulations of patients with major depression, and pharmacological
inhibition of COX-2 has been shown in clinical trials to decrease depressive symptoms of
patients with major depression [15-18]. Rodent studies indicate that increased COX2 expression
in the brain susceptibility to chronic mild unpredictable stress in rats and that COX2 inhibition
decreases anxiety-like behavior in mice and decreases glutamatergic activity in the amygdala
[19, 20]. To determine whether emulsifier-induced differences in stress responsivity were related

CONSUMPTION OF DIETARY EMULSIFIERS

50

to differences in inflammatory processes, we tested whether concomitant aspirin treatment (COX
inhibitor) would ameliorate emulsifier-induced increases in responsivity to social stress.
3.2
3.2.1

Methods
Animals
Adult male, C57BL/6J mice were obtained from the breeder at 8 weeks of age (The

Jackson Laboratory, Bar Harbor, ME). Upon arrival, they were group-housed 5 per cage in
ventilated, Allentown, NexGen plastic cages with corncob bedding until behavioral
manipulations began. Male CD-1, retired breeder mice (Charles River Laboratories) were singly
housed in the cages described above and were used as resident aggressors during social defeat.
After social defeat training or control manipulations, all C57BL/6J mice were then singly
housed. All mice were maintained on a 12:12 hour light/dark cycle, and food and water were
supplied ad libitum. All manipulations were performed during the first three hours of the dark, or
active, phase of the daily light-dark cycle. All procedures were approved by and performed in
accordance with the guidelines of the Institutional Animal Care and Use Committee (IACUC) at
Georgia State University and with national regulations and policies. This study was performed in
accordance with Animals in Research: Reporting In Vivo Experiments (ARRIVE) guidelines.
3.2.2

Procedure
Dietary manipulations: As per our earlier studies [9-11], to test the effects of emulsifiers

on stress-induced endpoints, C57BL/6J mice (n=7-8/group) were supplied with water bottles
containing either water with 1% sodium carboxymethylcellulose (CMC; Sigma, St. Louis, MO ),
water with 1% polysorbate-80 (P80; Sigma), or a water-only control as in our previous study [9,
11]. We have previously shown that similar results were obtained following emulsifier ingestion
in either food or drinking water [9]. After 12 weeks of emulsifier or control treatment, C57BL/6J
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mice were subjected to a 3 x 5-minute social defeat as detailed below. In experiments testing an
anti-inflammatory intervention, the groups described above were further divided into aspirin
(25mg/kg/day) or no aspirin groups. Aspirin was added to the drinking water or respective
emulsifier treatment from weeks 6 to 12 (n=7-8/per group) as per Roher et. al [21].
3.2.3

Social Defeat
Screening of aggressor CD-1 mice used in defeat training: CD-1 mice with consistent

levels of aggressive behaviors, as determined from a 3-day prescreening process, were used in
social defeats of C57BL/6J subjects. Briefly, each day a C57BL/6 mouse was placed in the home
cage of a CD-1 aggressor for 5 minutes. Only CD-1 mice whose latency to attack was
consistently less than 30 seconds were used for subsequent social defeat training.
Social Defeat Training and No Defeat Controls: Subjects were subjected to three, 5-min
defeat sessions on a single day with a 5 min inter-trial interval between each session during
which mice were returned to their home cages. The 5 min defeat sessions were timed from the
onset of the first attack by the RA. All animals were monitored during the defeat experience to
ensure that no physical injuries occurred. During training, no defeat controls were placed into an
empty RA/CD1 cage for the same duration of time as defeated animals to control for handling
and exposure to a novel cage with social odors. All social defeats and control manipulations
occurred during the first three hours of the dark phase of the daily light-dark cycle. All subjects
were singly-housed following defeat/novel cage exposure for the duration of the experiment.
3.2.4

Testing of Anxiety-like Behavior
Social Avoidance Testing: 24 hours after social defeat, the social avoidance of

experimental animals was tested as in Golden et. al [22]. Briefly, the time animals spent
investigating an empty box placed on one side of a neutral arena over 2.5 minutes was compared
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to the time spent investigating the box containing a novel CD-1 stimulus over the subsequent 2.5
minutes. Investigation of the empty box provided a baseline measure of non-social investigation
of a novel object, while also serving to habituate the animal to the box. A preference index was
calculated as [(interaction time, stimulus mouse-present)/( interaction time, stimulus mousepresent + interaction time, empty)] to indicate the overall level of social avoidance while
controlling for the possible confounding variable of novel object avoidance (or neophobia)[23,
24]. The social preference index varies from 0 to 1, where a preference index > 0.5 indicates a
preference for social interaction and an index < 0.5 indicates social avoidance.
3.2.5

ELISA
Serum Corticosterone and Prostaglandin E2 (PGE2)- Animals were subjected to social

defeat as described above and trunk blood was collected 20 minutes after the final social defeat.
After collection of the whole blood, it was allowed to clot at room temperature for 30 minutes.
Blood was centrifuged and serum was isolated for use in an enzyme-linked immunosorbent assay
(ELISA). Corticosterone and PGE2 were measured with commercially available ELISA kits
according to the manufacturer’s instructions (ENZO Life Sciences, Ann Arbor, MI, USA).
Standards and samples were added in duplicate to the wells of the microtiter plate. Optical
density was measured using an MD SPECTRAmax plate reader. The serum concentration of
corticosterone and PGE2 was calculated according to the standard curves.
Fecal Lipocalin 2 (Lcn-2) – To collect feces, mice were placed in a clean cage 20
minutes before euthanasia and 3-5 fresh fecal pellets were collected from the cage and flash
frozen. Fecal pellets were reconstituted in PBS containing 0.1% Tween 20 (100 mg/ml) and
vortexed for 20 min to get a homogenous fecal suspension. Samples were then centrifuged for 10
min at 12,000 rpm and 4°C. Clear supernatants were collected and stored at −20°C until analysis
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[25]. Lcn-2 levels were estimated in the supernatants using an Lcn-2 ELISA kit according to the
manufacturer’s instructions (R&D Systems, Minneapolis MN, USA). Standards and samples
were added in duplicate to the wells of the microtiter plate. The concentration of Lcn-2 was
calculated according to the standard curve.
3.2.6

Immunofluorescent Labeling
90 minutes after social defeat, animals were deeply anesthetized with isoflurane and then

perfused with 0.05 M PBS followed by 4% paraformaldehyde. Brains were postfixed in 4%
paraformaldehyde overnight at 4°C and then placed into a 30% sucrose solution. Brains were
coronally sectioned at 40µm on a cryostat. A series of coronal sections were obtained from the
infralimbic (IL) and prelimbic (PL) areas of the medial prefrontal cortex (mPFC), nucleus
accumbens (NAc), paraventricular nucleus (PVN), and basolateral (BLA). Sections were
incubated with an anti-c-Fos antibody (1:1000, Abcam, Cat# ab222699) overnight at 4 °C,
followed by incubation with an Alexa Fluor 488 conjugated goat anti-rabbit antibody (1:1000,
Abcam, Cat# ab150077) for 1 h at room temperature. Sections were cover-slipped and nuclei
counterstained with 4′,6-diamidino-2-phenylindole (DAPI) antifade mounting media. 10x images
were captured with a Keyence microscope with a digital camera. Positive c-Fos cell counts were
quantified using CellProfiler and were normalized to total cell counts in each respective region
analyzed.
3.2.7

Physiological Parameters: Hydration, Locomotion, and Body Composition
Liquid intake: To verify that the emulsifier and aspirin treatments did not alter the

volume of liquid ingested, liquid intake was measured over 7 days (N=7-8/group). Upon being
singly housed, mice were given a 50ml sipper tube filled with one of the emulsifiers in water or
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plain water. Volume within the sipper bottle was logged daily for 7 consecutive days to
determine the total ml of fluid ingested.
Open Field Testing: 48 hours after social defeat, exploratory behavior was measured.
Individual mice were placed in the center of a transparent plastic (50 cm × 50 cm) chamber, and
their behavior was monitored for 10 min with an overhead video-tracking system (Med
Associates Inc., Fairfax, VT). Total distance traveled was used as a measure of general activity,
to control for the potential confound of differences in overall health driving effects.
Echo Magnetic Resonance Imaging (eMRI): In addition to the liquid intake measures, the
body composition of each subject within the aspirin experiment was measured using an
EchoMRI 1100 (EchoMRI LLC, Houston, TX, USA) to determine whether emulsifier or aspirin
intake altered body composition or hydration compared to that observed in mice drinking only
water. Briefly, animals were weighed and inserted into the eMRI restrainer tube. The tube was
then inserted into the eMRI machine and body composition was measured. This procedure is
non-invasive and does not require the use of anesthesia. Tubes were disinfected with 70%
ethanol between testing each mouse. Parameters were measured in triplicate with each of the
three measurements lasting approximately 30 seconds. Measures collected included body mass,
total body fat, lean body mass, free water, and total body water content. A hydration ratio was
obtained by using the following equation: (total water – free water/ lean mass).
3.2.8

Statistics
Datasets were analyzed using GraphPad Prism (GraphPad Software, San Diego, CA) and

SPSS (SPSS Inc., Chicago, IL). Assumptions of ANOVA were tested and met. Statistical
significance was assessed using analysis of variance and significant main effects and interactions
relevant to the hypotheses were probed with Fisher's LSD or Tukey’s post hoc tests. Sample
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sizes and statistical tests are indicated in the figure legends and were considered statistically
significant when <0.05. All plots show mean ± SEM. p-values and effect sizes are indicated in
the results section. The effect size value was evaluated using partial eta-squared (hp2).
3.3
3.3.1

Results
Emulsifier consumption increases defeat-induced social avoidance but not novel object
avoidance
In Experiment 1, we examined social avoidance behavior 24 hours after exposure to

defeat (D) or no defeat (ND; novel cage exposure) to determine whether emulsifier consumption
behaviorally sensitizes animals to social stress (experimental timeline shown in Figure 3.1a). No
defeat controls demonstrated a preference for social interaction regardless of dietary treatment
compared to defeated mice, which displayed a significant reduction in social preference index
(F(1,54) 43.739; p<.001; hp2 = .448; Figure. 3.1b). Interestingly, pairwise comparisons revealed
that defeated animals that consumed emulsifiers showed a significant reduction in social
preference index compared to defeated animals that consumed water (D CMC v D Water; =.026)
and (D P80 v D Water; p=.03), suggesting that dietary emulsifier consumption increases social
avoidance after defeat. In addition, social defeat significantly reduced time spent investing a
novel object (empty box) (F (1,54) 31.061; p<.001; hp2 .365; Figure. 3.1c), however, no
significant differences were found between dietary groups. Together, these data suggest that
emulsifier consumption increases social anxiety but not general anxiety-like behavior in response
to defeat.

Experiment 2 timeline: Neuronal activation response to social defeat after emulsifier
consumption

12 weeks
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a
Experiment 1 timeline: Behavioral response to social defeat after emulsifier
consumption

12 weeks

24 hrs

Emulsifier treatment

3 x 5 min
Defeat

Social Avoidance
Testing

c

b

Social
Preference

Social
Indifference

Social
Avoidance

Figure 3.1 Exp 1 Dietary emulsifiers increase social avoidance after social defeat but do
not affect social preference in non-defeated mice and do not alter defeat-induced avoidance of a
novel object (empty box trial).
Note: Mice were given drinking water, alone, or water containing 1% of either CMC or P80.
Experiment timeline (a) social preference index (b) and time spent investigating empty box (c) across
defeated and no defeat dietary groups (N= 10 per group, data presented as means ±SEM; individual data
points represent 1 or more animals). 2x3 ANOVA analysis was conducted and multiple comparisons were
made using Tukey’s post hoc tests. *p <.05

3.3.2

Emulsifier consumption increases neural activity in stress-modulatory brain regions
Activation of neurons induces the expression of immediate early genes, such as c-fos and

subsequently c-fos protein, which are reliable markers of neuronal activity [26, 27]. Increased
neural activity in areas of the brain that modulate the stress response is associated with increased
behavioral sensitivity to various psychological stressors [12, 28, 29]. Our previously published
RNA-Seq data indicate that animals that chronically consumed emulsifiers showed increased
immediate early gene expression in the amygdala and PVN compared to controls that consumed
water [11]. In Experiment 2, we evaluated whether protein expression of the immediate early
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gene c-fos is increased in various stress-modulatory brain regions under control or social stress
conditions as a result of chronic emulsifier consumption (Figure 3.2a). Representative examples
of c-Fos and DAPI staining and how they were quantified are shown in Figure 3.2b.
The medial prefrontal cortex (mPFC) is a critical structure that regulates the HPA axis
response to psychological stressors [27, 30]. The mPFC represses HPA-axis activity largely
through functionally distinct subregions such as the prelimbic cortex (PL) and infralimbic cortex
(IL) that are heavily interconnected with stress modulatory regions, such as the basolateral
amygdala (BLA) and project directly to PVN [27, 31]. Defeat significantly increased c-Fos
expression compared to the ND group in the PL (F= 4.775; p=.039; hp2 =.166) and IL (F= 7.591;
p=.011; hp2 =.24; Figure 3.2c). Pairwise comparisons revealed that animals that consumed P80,
specifically, showed significantly greater c-Fos expression in the defeat condition compared to
P80-treated animals in the ND group (p=.008). This effect was only present in the IL and not in
the PL subregion of the mPFC.
The nucleus accumbens (NAc) is a stress-responsive brain region that mediates goaldirected behavior and salience [30]. The NAc receives input from both the BLA and PVN, which
are stress-sensitive brain regions that modulate HPA activity [31]. Defeat significantly increased
c-Fos expression compared to the ND group in the NAc (F= 8.487; p=.008; hp2 =.261; Figure
3.2d). Pairwise comparisons revealed that animals that consumed CMC, specifically, showed
significantly greater c-Fos expression in the defeat condition compared to CMC-treated animals
in the ND group (p=.046).
Within the PVN, defeat significantly increased neuronal activity compared to the ND
group (F=118.08 ; p<.01; hp2 = .831; Figure 3.2e). A significant dietary effect was present only
between CMC-treated mice and controls within the ND condition (p=.005). Within the BLA,
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a
Experiment 2 timeline: Neuronal activation response to social defeat after emulsifier
consumption

12 weeks

90 min

Emulsifier treatment

3 x 5 min
Defeat
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Experiment 1 timeline: Behavioral response
c-Fosto social defeat after emulsifier
c-Fos
consumption

12 weeks
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DAPI

Social Avoidance
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Figure 3.2 Emulsifier consumption elicits distinct c-Fos expression patterns across
various stress-modulatory brain regions under basal and stress conditions
Note: Experiment 2 timeline (a). Immunofluorescent c-Fos+ cells and DAPI-labeled nuclei within
brain regions of interest were counted automatically with CellProfiler. As an example, within the BLA
region of interest, c-Fos+ and DAPI+ nuclei recognized and auto-counted by CellProfiler are outlined in
green. Immunofluorescent artifacts or partial nuclei/cells outlined in magenta are not counted. % c-Fos
positive cells were computed using the following equation [c-FOS counts/ DAPI counts x100]. Counts
were obtained within the corresponding coordinates from Paxinos and Franklin’s mouse brain atlas as
adapted in sections shown on left of each panel (b-f). Quantification of % c-Fos positive cells within each
brain region under no defeat and social defeat conditions across dietary conditions were calculated and
data are presented as means ± SEM. N=5 per group and individual data points represent 1 or more
animals. 2x3 ANOVA analysis was conducted and multiple comparisons were made using Tukey’s post
hoc tests. * p <.05, ** p<.01, *** p<.005, **** p<.001 (c-f).
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there was a significant main effect of defeat (F=12.098; p=.002; hp2 = .335 Figure. 2f)
and a significant main effect of diet (F=12.098; p=.002; hp2 = .335). CMC and P80-treated
groups within the ND condition showed increased BLA neural activity compared to control
animals that consumed water (CMC p=.02, P80 p=.04). CMC and P80-treated groups within the
defeat condition also showed significantly increased neural activity compared to their watertreated controls (CMC p=.006, P80 p=.005). Increased c-Fos expression within the emulsifier
conditions is of particular concern, as BLA hyperactivity is associated with anxiety-like behavior
and HPA-axis dysfunction [32].
3.3.3

Aspirin treatment ameliorates the heightened sensitivity to social defeat in emulsifiertreated animals
We recently reported that animals consuming CMC or P80 show increased expression of

COX2 (PTG2) in the amygdala [11]. Other studies suggest that increased COX2 expression in
the amygdala is associated with increased susceptibility to chronic, mild, unpredictable stress in
rats, and COX inhibition decreases anxiety-like behavior in mice [19, 20]. Thus, we identified
the COX pathway as a possible mechanistic candidate driving the increased sensitivity to social
stress in mice that consumed emulsifiers. In Experiments 3 and 4 (timelines in Figure 3.3a),
animals were treated as in Experiment 1 but further divided into aspirin or no aspirin groups.
Aspirin (25mg/kg/day) was added to the drinking water or respective emulsifier treatment from
weeks 6 to 12. In Exp. 3, we measured social avoidance behavior 24 hours after exposure to
defeat or ND to determine whether COX inhibition ameliorates the increased sensitivity to social
stress that was observed in animals that consume dietary emulsifiers. No defeat controls
demonstrated a preference for social interaction regardless of dietary or aspirin treatment
compared to defeated animals, which displayed a significant reduction in social preference index
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(F(1, 78) = 27.470; p < .001; hp2 = .260; Figure. 3b). Within the no aspirin groups, pairwise
comparisons showed that defeated animals that consumed water did not significantly differ from
no defeat animals that consumed water, however, defeated, CMC-treated animals and defeated
P80-treated animals showed a significant reduction in social preference index compared to their
respective no defeat counterparts (D CMC vs ND CMC; p=.003) (D P80 vs ND P80; p=.008).
Within the aspirin group, a significant difference was found between defeat and ND in the watertreated animals (p=.022), however no significant differences were found between defeated
animals and ND in emulsifier-treated animals.
A significant interaction between dietary condition and aspirin treatment was found when
evaluating time spent investigating the empty box (F = (2, 78) 5.103 p = .008 hp2 = .116; Figure
3.3c). Pairwise comparisons revealed a significant decrease in time spent investigating the empty
box in defeat animals compared to no defeat animals in every dietary condition across aspirin
treatments except in aspirin-treated animals that consumed CMC (No Aspirin; D water vs ND
water, p=.002, D CMC vs ND CMC, p=.003, D P80 vs ND P80, p=.007) (Aspirin; D water vs
ND water, p=.003, D P80 vs ND P80, p=.01)
To evaluate whether emulsifier treatment increases hormonal sensitivity to social stress
and if aspirin ameliorates emulsifier-induced hormonal sensitivity, a separate group of animals
(Experiment 4) received emulsifier and aspirin treatment as described above and were sacrificed
20 minutes post-defeat. A factorial ANOVA was conducted to analyze the interaction of diet,
defeat, and aspirin on serum corticosterone. The interaction of the three variables was significant
(F (2, 78) = 3.994, p = .022; !p2 = .093; Figure. 3d). The interaction of diet and aspirin was
significant (F (1, 78) = 23.502, p <.001; !p2 = .232) and the interaction of defeat and diet was
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a
Experiment 3 timeline: Behavioral response to social defeat after emulsifier
consumption with aspirin intervention
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Experiment 4 timeline: Corticosterone response to social defeat after emulsifier
consumption with aspirin intervention
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Figure 3.3 Aspirin treatment reverses the emulsifier-induced enhancement of defeatinduced social avoidance and corticosterone release.
Note: Experimental timelines for Experiments 3 and 4 (a). Social preference index across defeated and
not defeated dietary groups that were given aspirin or not (b). Time spent investigating empty box across
defeated and not defeated dietary groups that were given aspirin or not (c). Serum corticosterone
concentration 20 minutes post-defeat (d). N= 7-8 per group and individual data points represent 1 or more
subjects; data presented as means ± SEM. 2x2x3 ANOVA analysis was conducted and pairwise
comparisons were made using Fisher’s LSD post hoc tests. *significantly lower than no defeat group p
<.05 (b-c).
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significant (F (2, 78) = 5.631, p = .005; !p2 = .126). Results also indicated main effects for defeat
(F (2, 78) = 23.854, p < 001 !p2 = .750) and diet (F (2, 78) = 5.222, p = .007; !p2 = .118).
Defeated animals showed significantly higher serum corticosterone levels (p <. 001). Within the
defeated group, pairwise comparisons indicated that animals given CMC that also received
aspirin showed significantly lower serum corticosterone (p < .001). When looking at differences
based on diet, animals on a P80 diet showed significantly higher serum corticosterone within the
non-defeated, non-aspirin group compared to water (p = .006) and CMC ( p = .059). For defeated
animals that did not receive aspirin, those given CMC had higher serum corticosterone than
those given water alone ( p <.001) and P80 (p < .001). There were no significant differences in
serum corticosterone across diets within the aspirin-treated animals regardless of defeat status.
Pairwise comparisons across aspirin-treated, non-defeated mice indicated that serum
corticosterone was significantly higher for the water (p < .001) and CMC (p = .004) animals
compared to animals that did not receive aspirin, suggesting that 6-week treatment with low-dose
aspirin may increase basal circulating corticosterone.
3.3.4

Emulsifier or aspirin treatment does not result in dehydration or general malaise
Potential confounding factors that could drive behavioral, hormonal, and brain activity

changes found in the current study are changes in fluid ingestion/hydration and physiological
symptoms associated with general malaise (Figure 3.4a). To assess the possibility that effects
seen in this study were secondary to changes in hydration or sickness rather than to the
emulsifier or aspirin treatments, themselves, various physiological and behavioral parameters
were compared across aspirin and dietary treatments after the social avoidance testing (full
timeline for Exp. 3 is shown in Figure 3.4a). Hydration measures included liquid intake and a
hydration ratio obtained by echo magnetic resonance imaging (eMRI). Parameters used to assess
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overall health also included body mass, fat mass, and locomotor activity. No significant
differences between groups were found in any measure across aspirin or dietary groups except
for liquid intake (Figure 3.4b), where animals that consumed P80 showed significantly more
liquid intake over 7 days than did animals that consumed water (p<.001). These data suggest that
animals that consume P80 may display polydipsia, a condition often associated with an anxietylike or abnormal metabolic phenotype [33]. However, alternative interpretations such as
increased palatability of P80 cannot be ruled out without doing preference testing. This
polydipsia did not, however result in changes in hydration (Figure 3.4c), body mass (Figure
3.4d), or fat mass (Figure 3.4d).
3.3.5

Verification of emulsifier-induced intestinal inflammation and aspirin suppression of
PGE2
Lipocalin-2 (LCN2), also known as neutrophil gelatinase-associated lipocalin (NGAL), is

a highly validated biomarker of gastrointestinal inflammation [34]. LCN2 is strongly expressed
in conditions where gastrointestinal damage, bacterial infection, or intestinal inflammation is
present [35, 36]. It has been previously reported that animals that consume emulsifiers show
elevations in fecal LCN2 [9], so we included at the end of Exp. 4 this measure to assess
emulsifier-induced intestinal state (experimental timeline is shown in Figure 3.5a). We found
that emulsifier treatment significantly increased fecal LCN2 levels (F(2, 84) = 5.534, p = .006,
!p2= .116; Figure. 3.5b), further supporting the contention that emulsifier treatment induces a
pro-inflammatory state. Post hoc comparisons revealed a significant increase in fecal LCN2 in
CMC-treated mice (p = .048) and P80-treated (p=.006) mice compared to water-treated controls.
Aspirin treatment had no significant effect on LNC2 levels, suggesting that aspirin did not
amplify or ameliorate emulsifier-induced intestinal inflammation.
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Experiment 3 timeline: Physiological measures following emulsifier treatment and
aspirin intervention
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Figure 3.4 Emulsifier or aspirin treatment does not result in physiological or behavioral
changes that would be expected if the treatments were associated with dehydration or general
malaise.
Note: An expanded experimental timeline for Experiment 3 is shown (a), liquid intake over 7
days between no aspirin and aspirin groups shows the addition of aspirin did not significantly affect liquid
intake but that P-80 resulted in increased water intake (p <.05) (b), hydration ratio as measured by eMRI
between no aspirin and aspirin groups and hydration ratio between dietary groups indicated no effect of
treatment on hydration, (c), no effect of treatment on body weight between no aspirin and aspirin groups
or between dietary groups (d), no effect of treatment on fat mass between no aspirin and aspirin groups or
between dietary groups (e), no effect of treatment on distance traveled over 10 minutes in the open field
between no aspirin and aspirin groups or between dietary groups (f). N=45 per experimental group for
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aspirin vs no aspirin comparisons and N=30 per experimental group for dietary comparisons, as data
displayed in each panel are collapsed across defeat and either aspirin treatment or dietary treatment
because acute defeat did not have a significant effect on physiological parameters. Data are presented as
means ± SEM. ANOVA analysis was conducted, and multiple comparisons were made using
Tukey’s post hoc tests. *p <.05 (b-f)

Prostaglandin E2 (PGE2) is elevated peripherally and centrally under inflammatory
conditions. PGE2 is synthesized from arachidonic acid by COX1 and COX2 and modulates the
production of pro-inflammatory cytokines [37]. NSAIDs inhibit COX production of PGE2,
therefore PGE2 measurement is often used to indicate the effectiveness of NSAIDs such as
aspirin [38, 39]. We found a significant main effect of aspirin on serum PGE2 (F (1, 78) =
17.037, p < .001, !p2 = .179; Figure 3.5c).
3.4

Discussion
Herein we provide the first evidence that dietary emulsifiers at percent doses regularly

consumed by humans can potentiate the neural activational, behavioral, and hormonal responses
to a relatively mild psychogenic stressor, namely acute social defeat stress. Emulsifier
consumption, alone, does not seem to illicit robust behavioral or hormonal responses until paired
with an additional salient stressor, suggesting that these food additives may drive susceptibility
to stressors. An exception to this, however, is that under basal conditions without social stress,
we do see increased neural activity within stress-modulatory regions of the brain such as the
PVN of CMC-treated mice and increased neural activity within the BLA, in both P80 and CMCtreated mice. The BLA is critical for the expression of anxiety and for the assignment of salience
to threating cues [40-43] Thus, it is possible that emulsifier consumption may “prime” fear
circuits to illicit a stronger anxiety-like behavioral response to social stress. The present data are
also consistent with previous research indicating that stress-modulatory brain regions show
increased neural activity under inflammatory conditions [44-47].
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a
Experiment 4 timeline: LCN2 and PGE2 measurements following emulsifier treatment
and aspirin intervention

12 weeks
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Figure 3.5 Inflammatory marker LCN2 increases after dietary emulsifier consumption
and PGE2 decreases with aspirin treatment.
Note: An expanded timeline for Experiment 4 is shown in (a). Fecal LCN2 concentrations were
significantly increased after emulsifier consumption (b), and serum PGE2 was reduced after aspirin
intervention (c). Data are collapsed across defeat status for aspirin or dietary treatment because acute
defeat did not have a significant effect on inflammatory markers. Data are presented as means ± SEM,
and data points represent 1 individual. N= 15 per group. ANOVA was conducted, and multiple
comparisons were made using Tukey’s post hoc tests. ** p<.01, **** p<.001 (b,c)

Mechanistically, it is reasonable to postulate that the enhanced responsivity to social
stress following emulsifier consumption may be due, at least in part, to the inflammatory COX
pathway, as inhibition of this pathway via aspirin administration reduced the emulsifier-induced
enhanced expression of social avoidance and corticosterone release. In principle, COX inhibition
may elicit anxiolytic effects via one or more mechanisms of action such as preventing
prostaglandin synthesis and the elevation of pro-inflammatory cytokines, increasing
endocannabinoid (eCB) levels, and/or reducing thromboxane TXA2. Many studies provide
strong evidence that COX inhibition of prostaglandin-driven inflammation decreases anxiety-like
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behavior and HPA-axis hyperactivity[48-50]. Alternatively, there is evidence that suggests COX
inhibition may have anxiolytic effects via eCB signaling, as substrate-selective inhibition of
COX-2, which increases brain eCB levels without decreasing prostaglandin levels, causes
cannabinoid receptor 1-dependent anxiolytic actions in mice [51]. Finally, it is also possible that
reductions in thromboxane TXA2, which is a platelet agonist and vasoconstrictor, contribute to
the anxiolytic-like actions of COX inhibitors. Metabolites of thromboxane TXA2 are highly
correlated with circulating cortisol levels in patients with major depressive disorder, however,
very little is currently known regarding its role in the regulation of stress responses and behavior
[52].
Aspirin is an irreversible COX1 and COX2 inhibitor. Both COX1 and COX2 are known
to induce PGE2, which engages the HPA axis during an immune challenge [53-55]. Given that
our recent studies suggest that emulsifier ingestion stimulates the release of immune markers and
that PTGS2 cyclooxygenase gene expression is enhanced in the brains of animals that consume
emulsifiers [9, 11]. future studies should go beyond a non-selective COX manipulation to
selectively inhibit COX1 or COX2. In addition, aspirin was administered systemically and its
metabolite, sodium salicylate, can readily pass the blood-brain barrier to inhibit COX action
centrally. Therefore, we cannot conclude from the present study whether aspirin affected the
HPA axis and behavior through a peripheral or central mechanism [56, 57]. However, various
studies suggest that the COX pathway affects HPA axis function centrally [58]. Additional
experiments in which COX inhibitors are administered selectively to specific stress-modulatory
brain regions will elucidate whether emulsifier-induced increases in sensitivity to social stress
occur via central COX action in a regionally specific manner.
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A potential confound we must highlight is that long-term aspirin use can be associated
with an increased likelihood of gastrointestinal damage, which can be of particular concern given
that emulsifier consumption may disrupt the mucosal barrier integrity in the gut [59]. Histology
of the gastrointestinal tract will need to be conducted to determine whether the damage is
present. Importantly, however, we measured body mass, liquid intake, and locomotor activity,
none of which were significantly impacted by emulsifier or aspirin treatment. Furthermore,
LCN2, a biomarker of intestinal damage and inflammation, did not increase following aspirin
administration, indicating that aspirin did not amplify emulsifier-induced intestinal
inflammation. Additionally, there are other studies indicating that low-dose aspirin does not
cause intestinal damage in mice [21, 60, 61]. The studies that do report aspirin-induced intestinal
damage used high doses of aspirin, upwards of 200mg/kg/day, over multiple days [62, 63].
Altogether, these data suggest that the aspirin effects reported herein are not likely due to aspirininduced intestinal damage.
Taken together, the present data demonstrate that ingestion of dietary emulsifiers, at
concentrations commonly ingested by humans, increases sensitivity to social stress and that
emulsifier consumption may impact social behavior and HPA-axis function at least in part via
the COX-molecular pathway. Thus, it is possible that consumption of dietary emulsifiers poses a
safety concern in humans wherein inflammation and dysregulation in stress responding can
ultimately lead to or exacerbate neuropsychiatric disease.
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FINAL CONCLUSIONS

Summary of current findings
It is only relatively recently that scientists have begun to recognize that the immune

system can impact brain and behavior and vice versa. For instance, we now know that chronic
inflammation can disrupt the HPA axis, increase susceptibility to social stress, and serve as an
underlying mechanism driving mood disorders [1-6]. Therefore, identifying and evaluating
environmental factors that may cause inflammation and immunological stress is important so that
we can learn how the increased risk resulting from this exposure can be mitigated. Dietary
emulsifiers are the most common food additives; they are generally viewed as innocuous and are
classified by the Food and Drug Administration (FDA) as generally recognized as safe (GRAS).
It has recently been demonstrated, however, that these additives, at translationally relevant doses,
can cause systemic inflammation and gut dysbiosis [7, 8]. Because recent studies have suggested
that emulsifier intake may increase basal anxiety-like behavior, we sought to determine whether
emulsifiers increase sensitivity to salient stressors, such as social defeat, and to identify
mechanisms that may underlie an anxiety-like phenotype. This project aimed to test the
overarching hypothesis that a dietary emulsifier-induced, proinflammatory state increases
sensitivity to social stress. First, we sought to determine whether the consumption of
emulsifiers, at doses that are used by the food industry, is sufficient to alter gene expression in
the brain thus offering a potential mechanism whereby these compounds may alter responses to
stress (Aim 1). Next, we tested whether emulsifier consumption increases sensitivity to social
stress. We investigated this aim by observing behavioral, hormonal, and neural activational
responses to social defeat stress in mice that consumed emulsifiers (Aim 2). Lastly, we tested the

CONSUMPTION OF DIETARY EMULSIFIERS

74

hypothesis that inflammation, specifically through the COX pathway, is a potential mechanism
driving emulsifier-induced stress sensitivity (Aim 3).
In Aim 1, we used RNA-Seq to measure gene expression in brain regions that are known
to be important in the generation of behavioral and neuroendocrine responses to stress-provoking
stimuli. This was measured in groups consuming either water containing 1%
carboxymethylcellulose or polysorbate 80 or plain water for 12-weeks. A total of 243 genes were
differentially expressed in the amygdala and PVN of emulsifier-treated mice compared to
controls. Interestingly, there was minimal overlap of differentially expressed genes in CMC- and
P80-treated animals, suggesting that each emulsifier may act via distinct molecular mechanisms
to produce an anxiety-like phenotype. The neurogenetic profile of emulsifier-treated animals,
which included differential expression many stress- and inflammation-related genes, suggested
that they would exhibit an increased sensitivity to stressors compared to controls, which
ultimately drove the investigation of this phenotype in Aim 2. In particular, we found that
emulsifier treatment increased expression of IEGs in the amygdala and PVN, suggesting that
both CMC and P80 increase neuronal activity in brain regions that modulate stress responding.
Further, differential expression of multiple HPA axis regulatory and responsive genes in
emulsifier-treated animals indicated possible dysregulation of the HPA axis. Lastly, the top
enriched canonical pathways in emulsifier-treated animals were largely comprised of altered
immune pathways in both the amygdala and PVN. These potential changes in central immune
activation are highly relevant, as increased neuroinflammation is proposed to be a driving factor
in the expression of anxiety and depression-like behavior [9]. One immune-related gene of high
interest that was differentially expressed (enhanced) in the amygdala of emulsifier-treated mice
as a result of emulsifier consumption was PTGS2 (COX2), a gene responsible for coding the
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enzyme that converts arachidonic acid to pro-inflammatory prostaglandins and regulating the
HPA axis [10, 11]. Thus, this pathway was identified as a prime mechanistic candidate that may
drive an anxiety-like phenotype.
Given the evidence provided in Aim 1, which highlighted several genetic markers of
HPA axis dysregulation in animals that consumed emulsifiers, Aim 2 investigated whether
emulsifier consumption, at percent doses regularly consumed by humans, increased sensitivity to
acute stress. We found that the consumption of these dietary emulsifiers potentiated the
behavioral, hormonal, and neuroactivational responses to a mild psychogenic stressor, namely
acute social defeat stress (ASDS). We did not find that emulsifier treatment, alone, elicited
robust behavioral or hormone responses until paired with ASDS. This finding suggests that these
emulsifiers may not be stimulating anxiety-like processes at baseline but may, instead, promote
susceptibility to stress. By contrast, however, we found that emulsifier treatment, alone, was
sufficient to illicit greater, basal neural activity, particularly within the BLA, even in the absence
of a stressor. Given that the BLA is a critical node in the brain controlling the signs and
symptoms of fear and anxiety and is thought influence the salience of social threat [10-13], it is
possible that emulsifier consumption “primes” fear circuits such that stronger anxiety-like
behavioral responses are then produced in response to stressors such as social stress.
In Aim 3, we sought to test a mechanism by which emulsifier consumption might
sensitize mice to social stress. We had identified the COX inflammatory pathway as a
mechanistic candidate based on our finding in Aim 1 that mice consuming dietary emulsifiers
show increased amygdala expression of COX2. We found that systemic inhibition of the COX
pathway via low-dose aspirin administration ameliorated the enhanced social avoidance and
circulating corticosterone seen in emulsifier-treated animals, leading us to conclude that the
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observed enhancement in stress responsivity observed in Aim 2 may be due, at least in part, to
the inflammatory COX pathway. Paradoxically, we found that controls consuming aspirin, alone,
without the emulsifier additive also showed increased social avoidance after social defeat when
compared to no aspirin control animals. This suggests that our aspirin regimen may only be
beneficial under inflammatory conditions and, under control conditions, may in fact exacerbate
social avoidance when inflammation is not present.
In sum, the present study tested the hypothesis that emulsifier intake, at doses that are
directly relevant to those ingested by humans, can influence gene expression in brain regions that
are known to be important in the generation of behavioral and neuroendocrine responses to
stress-provoking stimuli. The current findings illustrate the novel finding that dietary emulsifier
consumption induces genetic alternations within the brain, in particular the amygdala and PVN,
that could be associated with the previously reported anxiety-like phenotype [8]. Increased
neural activity in the amygdala and PVN is often associated with an anxiety- or depressive-like
phenotype in rodents and these may thus be brain regions within which emulsifiers act to
increase anxiety-like behavior [12]. Further, differential expression in emulsifier-treated animals
of multiple genes known to regulate the HPA axis and its response to stress indicates possible
emulsifier-induced dysregulation of the HPA axis.
4.2

Limitations and Future Directions
The results of our studies lay a strong foundation for others to further explore the impact

of and mechanisms whereby emulsifier consumption impacts stress responsivity. To our
knowledge, this is the first demonstration that these dietary additives may impact responses to
even a relatively mild social stressor. We wish to highlight some important limitations to the
studies presented here, however, so that future studies can address these points.
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Most obviously, the exclusion of females from this study is a clear limitation, as sex
differences in the prevalence of both inflammatory disease and stress-related neuropsychiatric
disorders exist in the clinical population [13, 14]. Previous studies [8] revealed potential sex
differences in anxiety-like and social behaviors in emulsifier-treated mice. Thus, it is entirely
possible that there are sex differences in the sensitivity to stress following emulsifier intake.
Though the social defeat stress model used in our study is a highly salient and translationally
relevant stressor [15, 16], it is not useful in female mice because CD1 aggressors will only defeat
males. Future studies should examine the effect of emulsifiers in other species, such as Syrian
hamsters, which are more conducive to testing sex differences in sensitivity to social defeat
because both sexes can be readily and similarly defeated by same-sex conspecifics. Future
studies could also use other types of stressors that can be equally applied to both males and
females to determine if sex differences in stress sensitivity are present in animals that consume
emulsifiers. An additional benefit of using a variety of stressors is that the data would reveal
whether the observed increase in stress sensitivity in emulsifier-treated animals is generalized or
is specific only to social stress.
Another limitation is that our current test of the proposed inflammatory mechanism of
action was very non-selective COX inhibition with aspirin treatment may affect HPA axis
functioning via several, downstream effector pathways. The use of a more specific manipulation
such as a selective COX inhibitor or the use of a conditional COX1 or COX2 knockout mouse
would delineate more specifically whether the effects seen in our study were due to inhibition of
the COX1 or COX2 pathway. Further, the route of aspirin administration used limits the
conclusions we can make regarding how and where aspirin is acting. In Aim 3, aspirin was
administered systemically. Though its metabolite, sodium salicylate, can readily pass the blood-
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brain barrier to inhibit COX action centrally, we cannot conclude whether the effects on HPA
axis function behavior occurred through a peripheral or central mechanism. Experiments in
which selective COX inhibitors are administered selectively to specific stress-modulatory brain
regions could elucidate whether emulsifier-induced social stress sensitivity acts via central COX
action, and if so, whether it does so in a brain region-specific manner.
The use of a selective COX2 inhibitor or central administration may also help mitigate
the potential confound that long-term, systemic aspirin use may result in gastrointestinal damage,
as the prostaglandins generated via the COX1 pathway are largely responsible for the integrity of
the mucosal barrier in the gut [17]. As discussed in the previous chapter, we did include some
measures to assess whether aspirin, itself, had deleterious effects on our subjects. Encouragingly,
we found that animals receiving aspirin did not show obvious physiological signs associated with
sickness nor did they exhibit higher fecal LCN2, a marker of intestinal damage. Thus, we
concluded that aspirin-induced intestinal damage or general malaise is not likely driving the
effects observed in our study, however, histological examination of the gastrointestinal tract was
not done in our studies. Future work could examine whether there is evidence of damage
following chronic administration of systemic COX inhibitors.
4.3

Final Summary and Impact
In conclusion, these data are the first to show that chronic emulsifier ingestion, which is

associated with alterations in gut microbiota and with low-grade inflammation [7, 8, 18], alters
gene expression in key brain areas that control stress-related behavior. The transcripts and
pathways highlighted here provide a more concrete understanding of the molecular mechanisms
by which emulsifier consumption may alter both HPA-axis functioning and stress-associated
behaviors. Further, these data demonstrate that ingestion of dietary emulsifiers, at concentrations
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commonly ingested by humans, increases sensitivity to social stress and that emulsifier
consumption may impact social behavior and HPA-axis function via the COX-molecular
pathway. From a translational perspective, it is possible that the long-term consumption of
emulsifiers may sensitize an individual to social stressors, which could further enhance overall
vulnerability to stress and increase the likelihood of developing stress-related neuropsychiatric
disorders. For this reason, consuming dietary emulsifiers may pose a safety concern to
consumers’ health as dysregulation in stress responsiveness can ultimately lead to
neuropsychiatric disease. More evidence clearly needs to be obtained so that this possibility can
be further tested. In the meantime, we maintain that the FDA should consider that certain food
additives, such as pro-inflammatory emulsifiers, could act as susceptibility factors to highly
detrimental neuropsychiatric disorders and should continue to evaluate whether such additives
should continue to be regarded as “generally recognized as safe.”
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